World Acceptance (WRLD) 10-Q 3 Feb 23 2023 Q3 Quarterly report Financial data

COVER

COVER - shares	9 Months Ended
	Dec. 31, 2022	Jan. 30, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	000-19599
Entity Registrant Name	WORLD ACCEPTANCE CORP
Entity Incorporation, State or Country Code	SC
Entity Tax Identification Number	57-0425114
Entity Address, Address Line One	104 S Main Street
Entity Address, City or Town	Greenville,
Entity Address, State or Province	SC
Entity Address, Postal Zip Code	29601
City Area Code	(864)
Local Phone Number	298-9800
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	WRLD
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		6,228,609
Entity Central Index Key	0000108385
Current Fiscal Year End Date	--03-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2022	Mar. 31, 2022
ASSETS
Cash and cash equivalents	$ 20,961,825	$ 19,236,322
Gross loans receivable	1,553,984,727	1,522,788,860
Less:
Unearned interest, insurance and fees	(431,297,470)	(403,030,844)
Allowance for credit losses	(144,539,543)	(134,242,862)
Loans receivable, net	978,147,714	985,515,154
Income taxes receivable	2,790,043	0
Operating lease right‐of‐use assets, net	83,437,329	85,631,304
Finance lease right‐of‐use assets, net	0	607,512
Property and equipment, net	24,377,670	24,476,231
Deferred income taxes, net	42,385,118	39,801,457
Other assets, net	41,104,168	35,901,704
Goodwill	7,370,791	7,370,791
Intangible assets, net	16,403,420	19,756,114
Total assets	1,216,978,078	1,218,296,589
Liabilities:
Senior notes payable	426,490,205	396,972,746
Senior unsecured notes payable, net	296,050,414	295,393,991
Income taxes payable	0	7,384,169
Operating lease liability	86,010,194	87,399,049
Finance lease liability	0	80,067
Accounts payable and accrued expenses	48,801,124	58,042,139
Total liabilities	857,351,937	845,272,161
Commitments and contingencies
Shareholders' equity:
Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding	0	0
Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 6,228,609 and 6,348,314 shares at December 31, 2022 and March 31, 2022, respectively	0	0
Additional paid-in capital	286,232,769	280,907,085
Retained earnings	73,393,372	92,117,343
Total shareholders' equity	359,626,141	373,024,428
Total liabilities and shareholders' equity	$ 1,216,978,078	$ 1,218,296,589

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2022	Mar. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	95,000,000	95,000,000
Common stock, shares issued (in shares)	6,228,609	6,348,314
Common stock, shares outstanding (in shares)	6,228,609	6,348,314

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Interest and fee income	$ 126,201,028	$ 128,147,374	$ 386,867,966	$ 355,435,289
Insurance and other income, net	20,295,432	20,424,437	68,449,330	60,622,784
Total revenues	146,496,460	148,571,811	455,317,296	416,058,073
Expenses:
Provision for credit losses	59,608,655	56,458,533	214,051,068	128,767,870
General and administrative expenses:
Personnel	40,700,713	44,383,906	131,173,726	136,361,580
Occupancy and equipment	12,932,456	12,613,622	39,658,067	39,155,558
Advertising	1,323,671	6,847,777	4,541,863	15,902,321
Amortization of intangible assets	1,114,540	1,275,784	3,352,694	3,736,113
Other	10,367,857	9,108,390	31,749,024	27,413,963
Total general and administrative expenses	66,439,237	74,229,479	210,475,374	222,569,535
Interest expense	14,070,458	10,166,125	38,277,223	22,380,850
Total expenses	140,118,350	140,854,137	462,803,665	373,718,255
Income (loss) before income taxes	6,378,110	7,717,674	(7,486,369)	42,339,818
Income tax expense (benefit)	619,136	390,942	(3,076,486)	6,802,166
Net income (loss)	$ 5,758,974	$ 7,326,732	$ (4,409,883)	$ 35,537,652
Net income (loss) per common share:
Basic (in dollars per share)	$ 1	$ 1.20	$ (0.77)	$ 5.81
Diluted (in dollars per share)	$ 0.98	$ 1.14	$ (0.77)	$ 5.53
Weighted average common shares outstanding:
Basic (in shares)	5,761,954	6,118,591	5,743,094	6,119,971
Diluted (in shares)	5,857,490	6,403,788	5,743,094	6,424,067

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings
Beginning balance (in shares) at Mar. 31, 2021		6,805,294
Beginning balances at Mar. 31, 2021	$ 404,927,441		$ 255,590,674	$ 149,336,767
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)		143,103
Proceeds from exercise of stock options	11,715,720		11,715,720
Common stock repurchases (in shares)		(289,158)
Common stock repurchases	(50,460,129)			(50,460,129)
Restricted common stock expense under stock option plan, net of cancellations (in shares)		(22,146)
Restricted common stock expense under stock option plan, net of cancellations	5,168,510		5,168,510
Stock option expense	2,517,071		2,517,071
Net income (loss)	35,537,652			35,537,652
Ending balance (in shares) at Dec. 31, 2021		6,637,093
Ending balances at Dec. 31, 2021	409,406,265		274,991,975	134,414,290
Beginning balance (in shares) at Sep. 30, 2021		6,724,140
Beginning balances at Sep. 30, 2021	419,007,341		272,572,177	146,435,164
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)		31,981
Proceeds from exercise of stock options	3,033,142		3,033,142
Common stock repurchases (in shares)		(93,722)
Common stock repurchases	(19,347,606)			(19,347,606)
Restricted common stock expense under stock option plan, net of cancellations (in shares)		(25,306)
Restricted common stock expense under stock option plan, net of cancellations	(1,277,438)		(1,277,438)
Stock option expense	664,094		664,094
Net income (loss)	7,326,732			7,326,732
Ending balance (in shares) at Dec. 31, 2021		6,637,093
Ending balances at Dec. 31, 2021	$ 409,406,265		274,991,975	134,414,290
Beginning balance (in shares) at Mar. 31, 2022	6,348,314	6,348,314
Beginning balances at Mar. 31, 2022	$ 373,024,428		280,907,085	92,117,343
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)		5,596
Proceeds from exercise of stock options	486,372		486,372
Common stock repurchases (in shares)		(73,643)
Common stock repurchases	(14,314,088)			(14,314,088)
Restricted common stock expense under stock option plan, net of cancellations (in shares)		(51,658)
Restricted common stock expense under stock option plan, net of cancellations	2,969,433		2,969,433
Stock option expense	1,869,879		1,869,879
Net income (loss)	$ (4,409,883)			(4,409,883)
Ending balance (in shares) at Dec. 31, 2022	6,228,609	6,228,609
Ending balances at Dec. 31, 2022	$ 359,626,141		286,232,769	73,393,372
Beginning balance (in shares) at Sep. 30, 2022		6,281,721
Beginning balances at Sep. 30, 2022	356,581,666		288,947,268	67,634,398
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)		1,296
Proceeds from exercise of stock options	82,825		82,825
Common stock repurchases	0
Restricted common stock expense under stock option plan, net of cancellations (in shares)		(54,408)
Restricted common stock expense under stock option plan, net of cancellations	(3,222,444)		(3,222,444)
Stock option expense	425,120		425,120
Net income (loss)	$ 5,758,974			5,758,974
Ending balance (in shares) at Dec. 31, 2022	6,228,609	6,228,609
Ending balances at Dec. 31, 2022	$ 359,626,141		$ 286,232,769	$ 73,393,372

CONSOLIDATED STATEMENTS OF SH_2

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Statement of Stockholders' Equity [Abstract]
Issuance of restricted common stock under stock option plan	$ 2,543,001	$ 4,922,017	$ 2,543,001	$ 5,072,230

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flow from operating activities:
Net income (loss)	$ (4,409,883)	$ 35,537,652
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss on assets held for sale	0	38,633
Amortization of intangible assets	3,352,694	3,736,113
Amortization of historic tax credits	4,570,599	2,950,970
Accrued unearned interest	(2,253,757)	(15,537,322)
Amortization of deferred loan cost	12,187,196	11,892,564
Amortization of debt issuance costs	1,170,040	698,667
Provision for credit losses	214,051,068	128,767,870
Depreciation	4,648,277	4,721,570
Amortization of finance leases	204,552	305,718
Gain on asset acquisition, net of income tax	(3,708,344)	0
Loss on sale of property and equipment	21,261	368,589
Deferred income tax benefit	(3,665,493)	(9,815,411)
Compensation related to stock option and restricted stock plans, net of taxes and adjustments	7,382,313	12,757,811
Change in accounts:
Other assets, net	(8,261,768)	(9,058,328)
Income taxes payable/ receivable	(10,174,212)	(9,984,485)
Accounts payable and accrued expenses	(9,241,015)	10,026,683
Net cash provided by operating activities	205,873,528	167,407,294
Cash flows from investing activities:
Increase in loans receivable, net	(189,511,989)	(421,230,379)
Cash paid for acquisitions, primarily loans	(22,314,902)	(10,857,067)
Purchases of property and equipment	(4,517,809)	(4,480,906)
Proceeds from sale of assets held for sale	0	1,104,895
Proceeds from sale of property and equipment	349,792	186,145
Net cash used in investing activities	(215,994,908)	(435,277,312)
Cash flow from financing activities:
Borrowings from senior notes payable	251,431,701	407,216,540
Payments on senior notes payable	(221,914,242)	(387,050,000)
Issuance of senior unsecured notes payable	0	300,000,000
Debt issuance costs associated with senior unsecured notes payable	(104,656)	(5,119,649)
Debt issuance costs associated with senior notes payable	(1,115,136)	0
Proceeds from exercise of stock options	486,372	11,715,720
Payments for taxes related to net share settlement of equity awards	(2,543,001)	(5,072,230)
Repayment of finance lease	(80,067)	(439,048)
Repurchase of common stock	(14,314,088)	(50,460,130)
Net cash provided by financing activities	11,846,883	270,791,203
Net change in cash and cash equivalents	1,725,503	2,921,185
Cash and cash equivalents at beginning of period	19,236,322	15,746,454
Cash and cash equivalents at end of period	20,961,825	18,667,639
Supplemental Disclosures:
Interest paid during the period	42,834,034	16,020,205
Income taxes paid during the period	10,772,869	26,884,025
Finance lease right-of-use assets, net transferred to property and equipment, net	$ 402,960	$ 0

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The consolidated financial statements of the Company at December 31, 2022 and for the three and nine months then ended were prepared in accordance with the instructions for Form 10-Q and are unaudited; however, in the opinion of management all adjustments (consisting only of items of a normal, recurring nature) necessary for a fair presentation of the financial position at December 31, 2022, and the results of operations and cash flows for the periods ended December 31, 2022 and 2021, have been included. The results for the interim periods are not necessarily indicative of the results that may be expected for the full year or any other interim period. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. Actual results could differ from those estimates.

ASSETS HELD FOR SALE

ASSETS HELD FOR SALE	9 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
ASSETS HELD FOR SALE	ASSETS HELD FOR SALEIn the fourth quarter of fiscal 2020 the Company moved its corporate headquarters from properties it owned outright in Greenville, South Carolina to leased office space in downtown Greenville, South Carolina. Under ASC 360-10, the properties met the criteria for classification as held for sale as of March 31, 2020. During the second quarter of fiscal 2021 the Company completed the sale of two of the three buildings held for sale. During the second quarter of fiscal 2022, the Company completed the sale of the last held for sale building, and recorded a $39.0 thousand loss on sale which is included as a component of Insurance and other income, net in the Consolidated Statements of Operations. As of December 31, 2022 and March 31, 2022, there were no assets held for sale.

SUMMARY OF SIGNIFICANT POLICIES

SUMMARY OF SIGNIFICANT POLICIES	9 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT POLICIES	SUMMARY OF SIGNIFICANT POLICIES Nature of Operations The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals. Seasonality The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters and operating results for its fourth fiscal quarter are generally higher than in other quarters. Loans receivable, net Loans receivable are carried at the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination fees and costs were $5.6 million and $6.9 million as of December 31, 2022 and March 31, 2022, respectively. From time to time, the Company may sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing . Allowance for credit losses Refer to Note 5, “Loans Receivable and Allowance for Credit Losses,” for information regarding the Company's CECL allowance model and a description of the methodology it utilizes. Reclassification Certain prior period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income or shareholders' equity. Recently Issued Accounting Standards Not Yet Adopted Troubled Debt Restructurings and Vintage Disclosures In March 2022, the FASB issued ASU 2022-02, Troubled Debt Restructurings and Vintage Disclosures . The amendments in this update eliminate the accounting guidance for troubled debt restructurings by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors , while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, for public business entities, the amendments in this update require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost . For entities that have adopted the amendments in Update 2016-13, the amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years and should be applied prospectively, with the exception of the transition method related to the recognition and measurement of troubled debt restructurings in which an entity has the option to apply a modified retrospective transition method. Early adoption is permitted. We are currently evaluating the impact the adoption of this update will have on our Consolidated Financial Statements. We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the Consolidated Financial Statements as a result of future adoption.

FAIR VALUE

FAIR VALUE	9 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Fair Value Disclosures The Company may carry certain financial instruments and derivative assets and liabilities at fair value measured on a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company measures the fair values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value measurements are grouped in three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are: • Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities. • Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active. • Level 3 – Unobservable inputs for assets or liabilities reflecting the reporting entity’s own assumptions. The Company’s financial instruments consist of cash and cash equivalents, loans receivable, net, senior notes payable, and senior unsecured notes payable. Loans receivable are originated at prevailing market rates and have an average life of approximately 8 months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s revolving credit facility has a variable rate based on a margin over SOFR and reprices with any changes in SOFR. The fair value of the senior unsecured notes payable is estimated based on quoted prices in markets that are not active. The Company also considers its creditworthiness in its estimation of fair value. The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below. December 31, 2022 March 31, 2022 Input Level Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value ASSETS Cash and cash equivalents 1 $ 20,961,825 $ 20,961,825 $ 19,236,322 $ 19,236,322 Loans receivable, net 3 978,147,714 978,147,714 985,515,154 985,515,154 LIABILITIES Senior unsecured notes payable 2 300,000,000 169,959,000 300,000,000 264,639,000 Senior notes payable 3 426,490,205 426,490,205 396,972,746 396,972,746 There were no other significant assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2022 or March 31, 2022.

LOANS RECEIVABLE AND ALLOWANCE

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES	9 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES	LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES The following is a summary of gross loans receivable by Customer Tenure as of: Customer Tenure December 31, 2022 March 31, 2022 0 to 5 months $ 110,657,069 $ 198,740,475 6 to 17 months 162,246,317 133,665,566 18 to 35 months 155,283,336 204,940,323 36 to 59 months 259,585,830 208,936,027 60+ months 866,191,770 770,683,149 Tax advance loans 20,405 5,823,320 Total gross loans $ 1,553,984,727 $ 1,522,788,860 Current payment performance is used to assess the capability of the borrower to repay contractual obligations of the loan agreements as scheduled, which is monitored by management on a daily basis. On an as needed basis, qualitative information may be taken into consideration if new information arises related to the customer’s ability to repay the loan. The Company’s payment performance buckets are as follows: current, 30-60 days past due, 61-90 days past due, 91 days or more past due. The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,315,496,157 $ 62,868,377 $ 2,458,233 $ 168,195 $ 14,977 $ 9,377 $ 1,381,015,316 30 - 60 days past due 51,922,222 6,178,714 256,692 56,562 19,357 1,314 58,434,861 61 - 90 days past due 35,259,645 3,682,972 175,892 45,534 1,175 — 39,165,218 91 or more days past due 66,796,641 8,345,331 182,449 17,029 5,211 2,266 75,348,927 Total $ 1,469,474,665 $ 81,075,394 $ 3,073,266 $ 287,320 $ 40,720 $ 12,957 $ 1,553,964,322 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ — $ — $ — $ — $ — $ — $ — 30 - 60 days past due — — — — — — — 61 - 90 days past due — — — — — — — 91 or more days past due 20,280 125 — — — — 20,405 Total $ 20,280 $ 125 $ — $ — $ — $ — $ 20,405 Total gross loans $ 1,553,984,727 The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,322,332,136 $ 34,273,199 $ 2,665,078 $ 152,105 $ 21,539 $ 3,972 $ 1,359,448,029 30 - 60 days past due 49,517,859 2,114,463 247,291 28,011 2,664 — 51,910,288 61 - 90 days past due 36,707,960 989,136 130,763 13,031 5,594 — 37,846,484 91 or more days past due 64,238,626 3,239,753 248,596 24,377 5,386 4,001 67,760,739 Total $ 1,472,796,581 $ 40,616,551 $ 3,291,728 $ 217,524 $ 35,183 $ 7,973 $ 1,516,965,540 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ 4,737,741 $ 7,033 $ — $ — $ — $ — $ 4,744,774 30 - 60 days past due 1,060,811 1,334 — — — — 1,062,145 61 - 90 days past due — 432 — — — — 432 91 or more days past due 2,922 13,047 — — — — 15,969 Total $ 5,801,474 $ 21,846 $ — $ — $ — $ — $ 5,823,320 Total gross loans $ 1,522,788,860 The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,296,198,737 $ 55,931,922 $ 2,010,305 $ 69,180 $ 4,343 $ 1,511 $ 1,354,215,998 30 - 60 days past due 52,162,519 3,578,939 86,368 8,801 — — 55,836,627 61 - 90 days past due 39,792,091 3,560,584 91,067 3,929 — — 43,447,671 91 or more days past due 81,321,318 18,003,948 885,526 205,410 36,378 11,446 100,464,026 Total $ 1,469,474,665 $ 81,075,393 $ 3,073,266 $ 287,320 $ 40,721 $ 12,957 $ 1,553,964,322 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ — $ — $ — $ — $ — $ — $ — 30 - 60 days past due — — — — — — — 61 - 90 days past due — — — — — — — 91 or more days past due 20,280 125 — — — — 20,405 Total $ 20,280 $ 125 $ — $ — $ — $ — $ 20,405 Total gross loans $ 1,553,984,727 The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,290,448,366 $ 29,913,995 $ 1,994,474 $ 68,836 $ 9,586 $ 699 $ 1,322,435,956 30 - 60 days past due 57,225,953 1,508,794 91,118 5,519 — — 58,831,384 61 - 90 days past due 45,276,797 1,271,187 96,233 986 — — 46,645,203 91 or more days past due 79,845,465 7,922,574 1,109,903 142,183 25,598 7,274 89,052,997 Total $ 1,472,796,581 $ 40,616,550 $ 3,291,728 $ 217,524 $ 35,184 $ 7,973 $ 1,516,965,540 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ 4,737,741 $ — $ — $ — $ — $ — $ 4,737,741 30 - 60 days past due 1,060,329 — — — — — 1,060,329 61 - 90 days past due — — — — — — — 91 or more days past due 3,404 21,846 — — — — 25,250 Total $ 5,801,474 $ 21,846 $ — $ — $ — $ — $ 5,823,320 Total gross loans $ 1,522,788,860 The allowance for credit losses is applied to amortized cost, which is defined as the amount at which a financing receivable is originated, and net of deferred fees and costs, collection of cash, and charge-offs. Amortized cost also includes interest earned but not collected. Credit Risk is inherent in the business of extending loans to borrowers and is continuously monitored by management and reflected within the allowance for credit losses for loans. The allowance for credit losses is an estimate of expected losses inherent within the Company’s gross loans receivable portfolio. In estimating the allowance for credit losses, loans with similar risk characteristics are aggregated into pools and collectively assessed. The Company’s loan products have generally the same terms therefore the Company looked to borrower characteristics as a way to disaggregate loans into pools sharing similar risks. In determining the allowance for credit losses, the Company examined four borrower risk metrics as noted below. 1. Borrower type 2. Active months 3. Prior loan performance 4. Customer Tenure To determine how well each metric predicts default risk the Company uses loss rate data over an observation period of twelve months at the loan level. The information value was then calculated for each metric. From this analysis management determined the metric that had the strongest predictor of default risk was Customer Tenure. The Customer Tenure buckets used in the allowance for credit loss calculation are: 1. 0 to 5 months 2. 6 to 17 months 3. 18 to 35 months 4. 36 to 59 months 5. 60+ months Management will continue to monitor this credit metric on a quarterly basis. Management estimates an allowance for each Customer Tenure bucket by performing a historical migration analysis of loans in that bucket for the twelve most recent historical twelve-month migration periods, adjusted for seasonality. All loans that are greater than 90 days past due on a recency basis and not written off as of the reporting date are reserved for at 100% of the outstanding balance, net of a calculated Rehab Rate. Management considers whether current credit conditions might suggest a change is needed to the allowance for credit losses by monitoring trends in first pay success for new borrowers, 60-day delinquencies, FICO scores and average loan size as compared to metrics in the historical migration period. Due to the short term nature of the loan portfolio, forecasted changes in macroeconomic variables such as unemployment do not have a significant impact on loans outstanding at the end of a particular reporting period. Therefore, management develops a reasonable and supportable forecast of losses by comparing the most recent 6-month loss curves as compared to historical loss curves to see if there are significant changes in borrower behavior that may indicate the historical migration rates should be adjusted. Additionally, changes to the Company's customer underwriting guidelines are considered to forecast credit losses. If an adjustment is made as a result of the forecast, then the Company has elected to immediately revert back to historical experience past the forecast period. The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2022 and 2021: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Beginning balance $ 155,892,100 $ 114,660,240 $ 134,242,862 $ 91,722,288 Provision for credit losses 59,608,655 56,458,533 214,051,068 128,767,870 Charge-offs (86,382,882) (42,359,511) (228,732,404) (102,226,061) Recoveries 1 15,421,670 4,521,934 24,978,017 15,017,099 Net charge-offs (70,961,212) (37,837,577) (203,754,387) (87,208,962) Ending Balance $ 144,539,543 $ 133,281,196 $ 144,539,543 $ 133,281,196 The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2022: Days Past Due - Recency Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 82,998,807 $ 7,076,046 $ 5,952,005 $ 14,630,210 $ 27,658,261 $ 110,657,068 6 to 17 months 134,510,770 8,584,660 6,300,110 12,850,778 27,735,548 162,246,318 18 to 35 months 131,660,006 7,375,720 5,497,643 10,749,967 23,623,330 155,283,336 36 to 59 months 233,507,760 9,554,628 6,062,913 10,460,529 26,078,070 259,585,830 60+ months 798,337,974 25,843,806 15,352,549 26,657,441 67,853,796 866,191,770 Tax advance loans — — — 20,405 20,405 20,405 Total gross loans 1,381,015,317 58,434,860 39,165,220 75,369,330 172,969,410 1,553,984,727 Unearned interest, insurance and fees (383,291,034) (16,218,182) (10,870,030) (20,918,224) (48,006,436) (431,297,470) Total net loans $ 997,724,283 $ 42,216,678 $ 28,295,190 $ 54,451,106 $ 124,962,974 $ 1,122,687,257 Percentage of period-end gross loans receivable 3.8% 2.5% 4.9% 11.1% The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2022: Days Past Due - Recency Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 145,168,588 $ 13,450,365 $ 14,196,717 $ 25,924,805 $ 53,571,887 $ 198,740,475 6 to 17 months 116,065,794 5,548,699 4,148,743 7,902,330 17,599,772 133,665,566 18 to 35 months 183,697,553 7,220,814 4,903,686 9,118,270 21,242,770 204,940,323 36 to 59 months 193,820,229 5,951,049 3,452,087 5,712,662 15,115,798 208,936,027 60+ months 720,695,865 19,739,361 11,145,251 19,102,672 49,987,284 770,683,149 Tax advance loans 4,744,774 1,062,145 432 15,969 1,078,546 5,823,320 Total gross loans 1,364,192,803 52,972,433 37,846,916 67,776,708 158,596,057 1,522,788,860 Unearned interest, insurance and fees (361,055,818) (14,020,016) (10,016,802) (17,938,208) (41,975,027) (403,030,844) Total net loans $ 1,003,136,985 $ 38,952,417 $ 27,830,114 $ 49,838,500 $ 116,621,030 $ 1,119,758,016 Percentage of period-end gross loans receivable 3.5 % 2.5 % 4.5 % 10.4 % The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2022: Days Past Due - Contractual Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 80,387,487 $ 6,499,221 $ 6,107,020 $ 17,663,341 $ 30,269,582 $ 110,657,069 6 to 17 months 131,366,771 8,013,659 6,864,901 16,000,987 30,879,547 162,246,318 18 to 35 months 128,007,181 6,759,902 5,969,417 14,546,835 27,276,154 155,283,335 36 to 59 months 229,416,636 9,123,648 6,838,567 14,206,979 30,169,194 259,585,830 60+ months 785,037,923 25,440,198 17,667,766 38,045,883 81,153,847 866,191,770 Tax advance loans — — — 20,405 20,405 20,405 Total gross loans 1,354,215,998 55,836,628 43,447,671 100,484,430 199,768,729 1,553,984,727 Unearned interest, insurance and fees (375,853,072) (15,497,061) (12,058,594) (27,888,743) (55,444,398) (431,297,470) Total net loans $ 978,362,926 $ 40,339,567 $ 31,389,077 $ 72,595,687 $ 144,324,331 $ 1,122,687,257 Percentage of period-end gross loans receivable 3.6% 2.8% 6.5% 12.9 % The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2022: Days Past Due - Contractual Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 140,570,461 $ 14,090,712 $ 15,380,836 $ 28,698,466 $ 58,170,014 $ 198,740,475 6 to 17 months 112,465,841 6,032,347 4,922,939 10,244,439 21,199,725 133,665,566 18 to 35 months 177,565,328 8,067,815 6,273,351 13,033,829 27,374,995 204,940,323 36 to 59 months 188,849,569 6,994,891 4,624,136 8,467,431 20,086,458 208,936,027 60+ months 702,984,756 23,645,619 15,443,941 28,608,833 67,698,393 770,683,149 Tax advance loans 4,737,742 1,060,329 — 25,249 1,085,578 5,823,320 Total gross loans 1,327,173,697 59,891,713 46,645,203 89,078,247 195,615,163 1,522,788,860 Unearned interest, insurance and fees (351,258,109) (15,851,316) (12,345,412) (23,576,007) (51,772,735) (403,030,844) Total net loans $ 975,915,588 $ 44,040,397 $ 34,299,791 $ 65,502,240 $ 143,842,428 $ 1,119,758,016 Percentage of period-end gross loans receivable 3.9 % 3.1 % 5.8 % 12.8 % The Company elected not to record an allowance for credit losses for accrued interest as outlined in ASC 326-20-30-5A. Loans are placed on nonaccrual status when management determines that the full payment of principal and collection of interest according to contractual terms is no longer likely. The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest revenue is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced. During the three months ended December 31, 2022 and December 31, 2021, the Company reversed a total of $9.4 million and $9.7 million, respectively, of unpaid accrued interest against interest income. During the nine months ended December 31, 2022 and December 31, 2021, the Company reversed a total of $29.9 million and $20.3 million, respectively, of unpaid accrued interest against interest income. The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as year-to-date interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2022 and 2021: Nonaccrual Loans Receivable Customer Tenure As of December 31, 2022 As of March 31, 2022 Interest Income Recognized for the three months ended December 31, 2022 Interest Income Recognized for the three months ended December 31, 2021 Interest Income Recognized for the nine months ended December 31, 2022 Interest Income Recognized for the nine months ended December 31, 2021 0 to 5 months $ 24,968,705 $ 45,227,510 $ 480,947 $ 293,649 $ 1,522,535 $ 858,871 6 to 17 months 23,995,420 15,879,250 450,877 325,759 1,216,091 1,151,316 18 to 35 months 21,946,855 20,745,106 544,689 504,974 1,741,780 1,414,201 36 to 59 months 22,662,926 14,232,388 555,085 325,291 1,575,766 978,378 60+ months 60,891,846 47,565,819 1,711,201 1,193,860 5,006,238 3,782,122 Tax advance loans 144,466 25,249 — — — — Unearned interest, insurance and fees (42,910,972) (38,026,011) — — — — Total $ 111,699,246 $ 105,649,311 $ 3,742,799 $ 2,643,533 $ 11,062,410 $ 8,184,888 As of December 31, 2022 and March 31, 2022, there were no loans receivable 61 days or more past due, not on nonaccrual status, and no loans receivable with no related allowance for credit losses.

LEASES

LEASES	9 Months Ended
	Dec. 31, 2022
Leases [Abstract]
LEASES	LEASES Accounting Policies and Matters Requiring Management's Judgment The Company uses its effective annual interest rate, adjusted for certain assumptions, as the discount rate when evaluating leases under Topic 842. Management applies the adjusted effective annual interest rate to leases entered for the entirety of the subsequent year. Based on its historical practice, the Company believes it is reasonably certain to exercise a given option associated with a given office space lease. Therefore, the Company classifies all lease options for office space as “reasonably certain” unless it has specific knowledge to the contrary for a given lease. The Company generally does not believe it is reasonably certain to exercise any options associated with its office equipment leases. Periodic Disclosures The Company's operating leases consist of real estate leases for office space as well as office equipment. Both the branch real estate and office equipment lease terms generally range from three years to five years, and generally contain options to extend which mirror the original terms of the lease. The Company's finance leases consist of IT equipment which have a three year lease term and do not contain an option to extend the lease term, but do contain an option to purchase the IT equipment at the expiration of the lease term. During the second quarter of fiscal 2023, the lease terms associated with the Company's finance leases expired and the Company exercised its purchase option to acquire the IT equipment. Because it was reasonably certain that the Company would obtain the assets at the end of their lease terms, the right-of-use assets have amortized over the useful life of the asset, rather than over the lease term. The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2022 and 2021: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Lease Cost Finance lease cost $ — $ 105,639 $ 205,975 $ 323,880 Amortization of right-of-use assets — 101,906 204,552 305,718 Interest on lease liabilities — 3,733 1,423 18,162 Operating lease cost $ 6,746,965 $ 6,723,789 $ 21,013,997 $ 20,421,780 Variable lease cost $ 920,991 $ 904,015 $ 2,772,620 $ 2,690,848 Total lease cost $ 7,667,956 $ 7,733,443 $ 23,992,592 $ 23,436,508 The following table reports other information about the Company's leases for the three and nine months ended December 31, 2022 and 2021: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Other Lease Information Cash paid for amounts included in the measurement of lease liabilities $ 6,550,184 $ 6,825,474 $ 19,998,398 $ 20,796,373 Operating cash flows from finance leases — 3,733 1,423 18,162 Operating cash flows from operating leases 6,550,184 6,684,414 19,916,908 20,339,163 Financing cash flows from finance leases — 137,327 80,067 439,048 Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ — $ — $ — Right-of-use assets obtained in exchange for new operating lease liabilities $ 3,447,091 $ 2,763,875 $ 13,912,470 $ 11,840,569 Weighted-average remaining lease term — finance leases — 0.5 years — 0.5 years Weighted average remaining lease term — operating leases 7.1 years 7.1 years 7.1 years 7.1 years Weighted-average discount rate — finance leases — % 6.1 % — % 6.1 % Weighted-average discount rate — operating leases 6.1 % 6.1 % 6.1 % 6.1 % The aggregate annual lease obligations as of December 31, 2022, are as follows: Operating Remainder of 2023 $ 6,357,453 2024 22,784,456 2025 18,108,324 2026 14,629,113 2027 10,545,420 Thereafter 35,219,893 Total undiscounted lease liability $ 107,644,659 Imputed interest 21,634,465 Total discounted lease liability $ 86,010,194 The Company had no finance lease obligations at December 31, 2022. The Company had no leases with related parties at December 31, 2022 or March 31, 2022.

AVERAGE SHARE INFORMATION

AVERAGE SHARE INFORMATION	9 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
AVERAGE SHARE INFORMATION	AVERAGE SHARE INFORMATION The following is a summary of the basic and diluted average common shares outstanding: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Basic: Weighted average common shares outstanding (denominator) 5,761,954 6,118,591 5,743,094 6,119,971 Diluted: Weighted average common shares outstanding 5,761,954 6,118,591 5,743,094 6,119,971 Dilutive potential common shares 2 95,536 285,197 — 304,096 Weighted average diluted shares outstanding (denominator) 5,857,490 6,403,788 5,743,094 6,424,067 Options to purchase 332,275 and 376,307 shares of common stock at various prices were outstanding during the three months ended December 31, 2022 and 2021 respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION Stock Incentive Plans The Company maintains a 2008 Stock Option Plan, a 2011 Stock Option Plan and a 2017 Stock Incentive Plan for the benefit of certain non-employee directors, officers, and key employees. Under these plans, a total of 3,350,000 shares of authorized common stock have been reserved for issuance pursuant to grants approved by the Compensation Committee. Stock options granted under these plans have a maximum term of 10 years, may be subject to certain vesting requirements, which are generally three Stock-based compensation is recognized as provided under FASB ASC Topic 718-10 and FASB ASC Topic 505-50. FASB ASC Topic 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the Consolidated Financial Statements based on their grant date fair values. The Company has applied the Black-Scholes valuation model in determining the grant date fair value of the stock option awards. Compensation expense is recognized only for those options expected to vest. Long-term Incentive Program and Non-Employee Director Awards On October 15, 2018, the Compensation Committee and Board approved and adopted a long-term incentive program that seeks to motivate and reward certain employees and to align management’s interest with shareholders’ by focusing executives on the achievement of long-term results. The program is comprised of four components: Service Options, Performance Options, Restricted Stock, and Performance Shares. Pursuant to this program, in fiscal 2019, the Compensation Committee approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the World Acceptance Corporation 2011 Stock Option Plan and the World Acceptance Corporation 2017 Stock Incentive Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Service Options and Restricted Stock to certain of the Company’s non-employee directors. Under the long-term incentive program, up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of two trailing earnings per share performance targets established by the Compensation Committee that are based on earnings per share (measured at the end of each calendar quarter, commencing with the calendar quarter ending September 30, 2019) for the previous four calendar quarters. The Performance Shares are eligible to vest over the Performance Share Measurement Period and subject to each respective employee’s continued employment at the Company through the last day of the Performance Share Measurement Period (or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement). The Performance Share performance targets are set forth below. Trailing 4-Quarter EPS Targets for Restricted Stock Eligible for Vesting $16.35 40% $20.45 60% The Restricted Stock awards vest in six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The Service Options vest in six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term. The Performance Options will fully vest if the Company attains the trailing earnings per share target over four consecutive calendar quarters occurring between September 30, 2018 and March 31, 2025 described below. Such performance target was established by the Compensation Committee and will be measured at the end of each calendar quarter commencing on September 30, 2019. The Performance Options are eligible to vest over the Option Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the Option Measurement Period or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term. The Performance Option performance target is set forth below. Trailing 4-Quarter EPS Targets for Options Eligible for Vesting $25.30 100% Stock Options The weighted-average fair value at the grant date for options issued during the three months ended December 31, 2022 and 2021 was $44.23 and $101.73, respectively. The weighted-average fair value at the grant date for options issued during the nine months ended December 31, 2022 and 2021 was $53.51 and $97.65, respectively. Fair value was estimated at grant date using the weighted-average assumptions listed below: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Dividend Yield —% —% —% —% Expected Volatility 57.46% 55.71% 57.09% 58.11% Average risk-free rate 3.91% 1.22% 3.59% 0.92% Expected Life 5.8 years 6.0 years 5.8 years 6.1 years The expected stock price volatility is based on the historical volatility of the Company's common stock for a period approximating the expected life. The expected life represents the period of time that options are expected to be outstanding after the grant date. The risk-free rate reflects the interest rate at grant date on zero coupon U.S. governmental bonds having a remaining life similar to the expected option term. Option activity for the nine months ended December 31, 2022 was as follows: Shares Weighted Average Exercise Weighted Average Aggregate Intrinsic Value Options outstanding, beginning of period 348,743 $ 104.38 Granted during period 15,090 96.15 Exercised during period (6,550) 84.67 Forfeited during period (20,636) 119.94 Expired during period (12,372) 77.78 Options outstanding, end of period 324,275 3 $ 104.42 5.9 years $ 262,799 Options exercisable, end of period 122,853 $ 100.21 5.0 years $ 233,927 The aggregate intrinsic value reflected in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on December 31, 2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by option holders had all option holders exercised their options as of December 31, 2022. This amount will change as the market price of the common stock changes. The total intrinsic value of options exercised during the periods ended December 31, 2022 and 2021 was as follows: December 31, December 31, Three months ended $ 51,106 $ 4,529,120 Nine months ended $ 481,572 $ 16,070,389 As of December 31, 2022, total unrecognized stock-based compensation expense related to non-vested stock options amounted to approximately $3.6 million, which is expected to be recognized over a weighted-average period of approximately 2.0 years. Restricted Stock During the nine months of fiscal 2023, the Company granted 2,750 shares of restricted stock (which are equity classified) to certain vice presidents, senior vice presidents, executive officers, and non-employee directors with a grant date weighted average fair value of $138.76 per share. During fiscal 2022, the Company granted 4,062 shares of restricted stock (which are equity classified) to certain vice presidents with a grant date weighted average fair value of $188.38 per share. Compensation expense related to restricted stock is based on the number of shares expected to vest and the fair market value of the common stock on the grant date. The Company recognized compensation benefit of $0.7 million and compensation expense of $3.6 million for the three months ended December 31, 2022 and 2021, respectively, which is included as a component of general and administrative expenses in the Company’s Consolidated Statements of Operations. The Company recognized compensation expense of $5.5 million and $10.2 million for the nine months ended December 31, 2022 and 2021, respectively, which is included as a component of general and administrative expenses in the Company’s Consolidated Statements of Operations. As of December 31, 2022, there was approximately $5.4 million of unrecognized compensation cost related to unvested restricted stock awards, which is expected to be recognized over the next 1.6 years based on current estimates. A summary of the status of the Company’s restricted stock as of December 31, 2022, and changes during the nine months ended December 31, 2022, are presented below: Shares Weighted Average Fair Value at Grant Date Outstanding at March 31, 2022 552,502 $ 102.51 Granted during the period 2,750 138.76 Vested during the period (65,518) 104.13 Forfeited during the period (29,620) 112.70 Outstanding at December 31, 2022 460,114 $ 101.84 Total Stock-Based Compensation Total stock-based compensation included as a component of net income (loss) during the three and nine month periods ended December 31, 2022 and 2021 was as follows: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Stock-based compensation related to equity classified awards: Stock-based compensation related to stock options $ 425,120 $ 664,094 $ 1,869,879 $ 2,517,071 Stock-based compensation related to restricted stock, net of adjustments and exclusive of cancellations 4 (679,443) 3,644,579 5,512,434 10,240,740 Total stock-based compensation related to equity classified awards $ (254,323) $ 4,308,673 $ 7,382,313 $ 12,757,811

ACQUISITIONS

ACQUISITIONS	9 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
ACQUISITIONS	ACQUISITIONS The Company evaluates each set of assets and activities it acquires to determine if the set meets the definition of a business according to FASB ASC Topic 805-10-55. Acquisitions meeting the definition of a business are accounted for as a business combination while all other acquisitions are accounted for as asset purchases. The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2022 and 2021. Nine months ended December 31, 2022 2021 Acquisitions: Number of loan portfolios acquired through asset purchases 43 50 Total acquisitions 43 50 Purchase price $ 22,314,902 $ 10,859,984 Tangible assets: Loans receivable, net 27,105,078 9,631,112 Purchase price amount over (below) carrying value of net tangible assets 5 $ (4,790,176) $ 1,228,872 Customer lists $ — $ 952,872 Non-compete agreements $ — $ 276,000 Acquisitions that are accounted for as business combinations typically result in one or more new branches. In such cases, the Company typically retains the existing employees and the branch location from the acquisition. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. The remainder is allocated to goodwill. Acquisitions that are accounted for as asset purchases are typically limited to acquisitions of loan portfolios. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. In an asset purchase, no goodwill is recorded. The Company’s acquisitions include tangible assets (generally loans and furniture and equipment) and intangible assets (generally non-compete agreements, customer lists, and goodwill), both of which are recorded at their fair values, which are estimated pursuant to the processes described below. Acquired loans are valued at the net loan balance. Given the short-term nature of these loans, generally 8 months, and that these loans are priced at current rates, management believes the net loan balances approximate their fair value. Under CECL, acquired loans are included in the reserve calculations for all other loan types (excluding TALs). Management includes recent acquisition activity compared to historical activity when considering reasonable and supportable forecasts as it relates to assessing the adequacy of the allowance for expected credit losses. The Company did not acquire any loans that would qualify as PCDs during the period. Furniture and equipment are valued at the specific purchase price as agreed to by both parties at the time of acquisition, which management believes approximates their fair values. Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates their fair value. Customer lists are valued with a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists. Customer lists are allocated at a branch level and are evaluated for impairment at a branch level when a triggering event occurs in accordance with FASB ASC Topic 360-10-05. If a triggering event occurs, the impairment loss to the customer list is generally the remaining unamortized customer list balance. In most acquisitions, the original fair value of the customer list allocated to a branch is less than $100,000, and management believes that in the event a triggering event were to occur, the impairment loss to an unamortized customer list would be immaterial. The estimated results of all acquisitions have been included in the Company’s Consolidated Financial Statements since the respective acquisition date. The pro forma impact of these branches as though they had been acquired at the beginning of the periods presented would not have a material effect on the results of operations as reported.

DEBT

DEBT	9 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
DEBT	DEBT Senior Notes Payable; Revolving Credit Facility At December 31, 2022, the Company had a $685.0 million senior revolving credit facility. The revolving credit facility was amended in connection with the Company’s Notes offering (described below) on September 27, 2021 to permit the issuance of the Notes described below and increase the amount of permitted borrowings under the accordion feature from $685.0 million to $785.0 million. On November 23, 2022, the revolving credit agreement was amended (the "Ninth Amendment") to, among other things, (1) change the required ratio for net income available for fixed charges to fixed charges to 1.25 to 1.0 for the fiscal quarter ending December 31, 2022, 1.15 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 1.50 to 1.0 for the fiscal quarter September 30, 2023, 2.0 to 1.0 for the fiscal quarter ending December 31, 2023, and 2.75 to 1.0 for each fiscal quarter thereafter, where the most recent four consecutive fiscal quarters must be at least 2.0 to 1.0 in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity; (2) change the ratio of total debt to consolidated adjusted net worth to 2.5 to 1.0 for the fiscal quarter ending December 31, 2022, 2.25 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 2.0 to 1.0 for the fiscal quarter ending September 30, 2023, 2.25 to 1.0 for the fiscal quarter ending December 31, 2023, and 2.5 to 1.0 for each fiscal quarter thereafter; (3) require a collateral performance indicator of less than or equal to 28% for the calendar months ending October 31, 2022 through June 30, 2023 and 26% thereafter; and (4) decrease the advance rate to as low as 62% from 74% for the calendar months ending October 31, 2022 through June 30, 2023. At December 31, 2022, $426.5 million was outstanding under the Company's credit facility, not including a $300.0 thousand outstanding standby letter of credit related to workers compensation under a $1.5 million sub-facility. To the extent that the letter of credit is drawn upon, the disbursement will be funded by the credit facility. There are no amounts due related to the letter of credit as of December 31, 2022. The letter of credit expired on December 31, 2021; however, it automatically extends for one year on the expiration date. Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus .10% and an applicable margin of 3.5% with a minimum rate of 4.5%. The revolving credit facility has a commitment fee of 0.50% per annum on the unused portion of the commitment. Commitment fees on the unused portion of the borrowing totaled $0.9 million and $1.0 million for the nine months ended December 31, 2022 and 2021, respectively. For the nine months ended December 31, 2022 and fiscal year ended March 31, 2022, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, was 6.8% annualized and 5.5%, respectively, and the unused amount available under the revolving credit facility at December 31, 2022 was $258.2 million. Borrowings under the revolving credit facility mature on June 7, 2024. Substantially all of the Company’s assets are pledged as collateral for borrowings under the revolving credit agreement. Senior Unsecured Notes Payable On September 27, 2021, we issued $300.0 million in aggregate principal amount of 7.0% senior notes due 2026 (the “Notes”). The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company may redeem the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company may use the proceeds of certain equity offerings to redeem up to 40.0% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes. Debt Covenants The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that generally restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement also contains financial covenants, including (i) a minimum consolidated net worth of $325.0 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth as further discussed below; (iii) a maximum collateral performance indicator as further discussed below; and (iv) a minimum fixed charges coverage ratio as further discussed below. As discussed above, on November 23, 2022, the Company entered into the Ninth Amendment to, among other things, (1) change the required ratio for net income available for fixed charges to fixed charges to 1.25 to 1.0 for the fiscal quarter ending December 31, 2022, 1.15 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 1.50 to 1.0 for the fiscal quarter September 30, 2023, 2.0 to 1.0 for the fiscal quarter ending December 31, 2023, and 2.75 to 1.0 for each fiscal quarter thereafter, where the most recent four consecutive fiscal quarters must be at least 2.0 to 1.0 in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity; (2) change the ratio of total debt to consolidated adjusted net worth to 2.5 to 1.0 for the fiscal quarter ending December 31, 2022, 2.25 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 2.0 to 1.0 for the fiscal quarter ending September 30, 2023, 2.25 to 1.0 for the fiscal quarter ending December 31, 2023, and 2.5 to 1.0 for each fiscal quarter thereafter; (3) require a collateral performance indicator of less than or equal to 28% for the calendar months ending October 31, 2022 through June 30, 2023 and 26% thereafter; and (4) decrease the advance rate to as low as 62% from 74% for the calendar months ending October 31, 2022 through June 30, 2023. The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate. The Company was in compliance with these covenants at December 31, 2022 and does not believe that these covenants will materially limit its business and expansion strategy. The revolving credit agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default and cross-acceleration to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible finance receivables that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change. If it is determined that a violation of any applicable law has occurred, such violation may give rise to an event of default under our credit agreement if such violation were to result in a material adverse change on our business, operations, results of operations, assets, liabilities, or condition (financial or otherwise), or a material impairment of the Company’s and the subsidiaries’ ability to perform their obligations under the agreement or related documents, or if the amount of any settlement, penalties, fines, or other payments resulted in the Company failing to satisfy any financial covenants. The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions. Debt Maturities The aggregate annual maturities of the Company's debt arrangements as of December 31, 2022 are as follows: Remainder of 2023 $ — 2024 — 2025 426,490,205 2026 — 2027 300,000,000 Total future debt payments $ 726,490,205

INCOME TAXES

INCOME TAXES	9 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES As of December 31, 2022 and March 31, 2022, the Company had $1.1 million and $2.2 million, respectively, of total gross unrecognized tax benefits including interest. Approximately $0.8 million and $2.0 million, respectively, represent the amount of net unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. At December 31, 2022, approximately $0.5 million of gross unrecognized tax benefits are expected to be resolved during the next twelve months through the expiration of the statute of limitations and settlement with taxing authorities. The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2022, the Company had approximately $271.5 thousand accrued for gross interest and reversed $284.0 thousand during the nine months ended December 31, 2022. The Company is subject to U.S. income taxes, as well as taxes in various other state and local jurisdictions. With the exception of a few states, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018, although carryforward attributes that were generated prior to 2018 may still be adjusted upon examination by the taxing authorities if they either have been or will be used in a future period. The Company’s effective income tax rate totaled 9.7% for the quarter ended December 31, 2022 compared to 5.1% for the prior year quarter. The increase is primarily due to the permanent benefit related to non-qualified stock option exercises and vesting of restricted stock as discrete items in the prior year quarter. This was partially offset by the effects of pretax book earnings relative to the effects of various permanent items including a decrease in the disallowed executive compensation under Section 162(m) and the recognition of additional Federal Historic Tax Credits when compared to the prior year quarter.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIESDerivative Litigation On September 25, 2020, a shareholder filed a derivative complaint in South Carolina state court, Paul Parshall v. World Acceptance et al ., against the Company as the nominal defendant and certain current and former directors and officers as defendants. Pointing to the Company’s resolution with the SEC and DOJ of the Mexico investigation previously disclosed, the complaint alleges violations of South Carolina law, including breaches of fiduciary duties and corporate waste, and that the Company has suffered damages as a result of those alleged breaches. The complaint seeks unspecified monetary damages from the individual defendants, equitable and/or injunctive relief, disgorgement of compensation from the individual defendants, and attorneys’ fees and costs. Because the complaint is derivative in nature, it does not seek monetary damages from the Company. However, the Company may be required to advance, and ultimately be responsible for, the legal fees and costs incurred by the individual defendants. General In addition, from time to time the Company is involved in litigation matters relating to claims arising out of its operations in the normal course of business. Estimating an amount or range of possible losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve fines, penalties or damages that are discretionary in amount, involve a large number of claimants or significant discretion by regulatory authorities, represent a change in regulatory policy or interpretation, present novel legal theories, are in the early stages of the proceedings, are subject to appeal or could result in a change in business practices. In addition, because most legal proceedings are resolved over extended periods of time, potential losses are subject to change due to, among other things, new developments, changes in legal strategy, the outcome of intermediate procedural and substantive rulings and other parties’ settlement posture and their evaluation of the strength or weakness of their case against us. However, in light of the inherent uncertainties involved, an adverse outcome in one or more of these matters could materially and adversely affect the Company’s financial condition, results of operations or cash flows in any particular reporting period.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTSManagement is not aware of any significant events occurring subsequent to the balance sheet date that would have a material effect on the financial statements thereby requiring adjustment or disclosure.

SUMMARY OF SIGNIFICANT POLICI_2

SUMMARY OF SIGNIFICANT POLICIES (Policies)	9 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.
Seasonality	Seasonality The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters and operating results for its fourth fiscal quarter are generally higher than in other quarters.
Loans receivable, net	Loans receivable, net Loans receivable are carried at the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination fees and costs were $5.6 million and $6.9 million as of December 31, 2022 and March 31, 2022, respectively. From time to time, the Company may sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing .
Allowance for credit losses	Allowance for credit losses Refer to Note 5, “Loans Receivable and Allowance for Credit Losses,” for information regarding the Company's CECL allowance model and a description of the methodology it utilizes.
Reclassification	Reclassification Certain prior period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income or shareholders' equity.
Recently Issued Accounting Standards Not Yet Adopted	Recently Issued Accounting Standards Not Yet Adopted Troubled Debt Restructurings and Vintage Disclosures In March 2022, the FASB issued ASU 2022-02, Troubled Debt Restructurings and Vintage Disclosures . The amendments in this update eliminate the accounting guidance for troubled debt restructurings by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors , while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, for public business entities, the amendments in this update require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost . For entities that have adopted the amendments in Update 2016-13, the amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years and should be applied prospectively, with the exception of the transition method related to the recognition and measurement of troubled debt restructurings in which an entity has the option to apply a modified retrospective transition method. Early adoption is permitted. We are currently evaluating the impact the adoption of this update will have on our Consolidated Financial Statements. We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the Consolidated Financial Statements as a result of future adoption.

FAIR VALUE (Tables)

FAIR VALUE (Tables)	9 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring and Nonrecurring	The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below. December 31, 2022 March 31, 2022 Input Level Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value ASSETS Cash and cash equivalents 1 $ 20,961,825 $ 20,961,825 $ 19,236,322 $ 19,236,322 Loans receivable, net 3 978,147,714 978,147,714 985,515,154 985,515,154 LIABILITIES Senior unsecured notes payable 2 300,000,000 169,959,000 300,000,000 264,639,000 Senior notes payable 3 426,490,205 426,490,205 396,972,746 396,972,746

LOANS RECEIVABLE AND ALLOWANC_2

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Tables)	9 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	The following is a summary of gross loans receivable by Customer Tenure as of: Customer Tenure December 31, 2022 March 31, 2022 0 to 5 months $ 110,657,069 $ 198,740,475 6 to 17 months 162,246,317 133,665,566 18 to 35 months 155,283,336 204,940,323 36 to 59 months 259,585,830 208,936,027 60+ months 866,191,770 770,683,149 Tax advance loans 20,405 5,823,320 Total gross loans $ 1,553,984,727 $ 1,522,788,860
Assessment of the Credit Quality	The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,315,496,157 $ 62,868,377 $ 2,458,233 $ 168,195 $ 14,977 $ 9,377 $ 1,381,015,316 30 - 60 days past due 51,922,222 6,178,714 256,692 56,562 19,357 1,314 58,434,861 61 - 90 days past due 35,259,645 3,682,972 175,892 45,534 1,175 — 39,165,218 91 or more days past due 66,796,641 8,345,331 182,449 17,029 5,211 2,266 75,348,927 Total $ 1,469,474,665 $ 81,075,394 $ 3,073,266 $ 287,320 $ 40,720 $ 12,957 $ 1,553,964,322 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ — $ — $ — $ — $ — $ — $ — 30 - 60 days past due — — — — — — — 61 - 90 days past due — — — — — — — 91 or more days past due 20,280 125 — — — — 20,405 Total $ 20,280 $ 125 $ — $ — $ — $ — $ 20,405 Total gross loans $ 1,553,984,727 The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,322,332,136 $ 34,273,199 $ 2,665,078 $ 152,105 $ 21,539 $ 3,972 $ 1,359,448,029 30 - 60 days past due 49,517,859 2,114,463 247,291 28,011 2,664 — 51,910,288 61 - 90 days past due 36,707,960 989,136 130,763 13,031 5,594 — 37,846,484 91 or more days past due 64,238,626 3,239,753 248,596 24,377 5,386 4,001 67,760,739 Total $ 1,472,796,581 $ 40,616,551 $ 3,291,728 $ 217,524 $ 35,183 $ 7,973 $ 1,516,965,540 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ 4,737,741 $ 7,033 $ — $ — $ — $ — $ 4,744,774 30 - 60 days past due 1,060,811 1,334 — — — — 1,062,145 61 - 90 days past due — 432 — — — — 432 91 or more days past due 2,922 13,047 — — — — 15,969 Total $ 5,801,474 $ 21,846 $ — $ — $ — $ — $ 5,823,320 Total gross loans $ 1,522,788,860 The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,296,198,737 $ 55,931,922 $ 2,010,305 $ 69,180 $ 4,343 $ 1,511 $ 1,354,215,998 30 - 60 days past due 52,162,519 3,578,939 86,368 8,801 — — 55,836,627 61 - 90 days past due 39,792,091 3,560,584 91,067 3,929 — — 43,447,671 91 or more days past due 81,321,318 18,003,948 885,526 205,410 36,378 11,446 100,464,026 Total $ 1,469,474,665 $ 81,075,393 $ 3,073,266 $ 287,320 $ 40,721 $ 12,957 $ 1,553,964,322 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ — $ — $ — $ — $ — $ — $ — 30 - 60 days past due — — — — — — — 61 - 90 days past due — — — — — — — 91 or more days past due 20,280 125 — — — — 20,405 Total $ 20,280 $ 125 $ — $ — $ — $ — $ 20,405 Total gross loans $ 1,553,984,727 The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2022: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 1,290,448,366 $ 29,913,995 $ 1,994,474 $ 68,836 $ 9,586 $ 699 $ 1,322,435,956 30 - 60 days past due 57,225,953 1,508,794 91,118 5,519 — — 58,831,384 61 - 90 days past due 45,276,797 1,271,187 96,233 986 — — 46,645,203 91 or more days past due 79,845,465 7,922,574 1,109,903 142,183 25,598 7,274 89,052,997 Total $ 1,472,796,581 $ 40,616,550 $ 3,291,728 $ 217,524 $ 35,184 $ 7,973 $ 1,516,965,540 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ 4,737,741 $ — $ — $ — $ — $ — $ 4,737,741 30 - 60 days past due 1,060,329 — — — — — 1,060,329 61 - 90 days past due — — — — — — — 91 or more days past due 3,404 21,846 — — — — 25,250 Total $ 5,801,474 $ 21,846 $ — $ — $ — $ — $ 5,823,320 Total gross loans $ 1,522,788,860
Summary of Changes in the Allowance For Loan Losses	The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2022 and 2021: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Beginning balance $ 155,892,100 $ 114,660,240 $ 134,242,862 $ 91,722,288 Provision for credit losses 59,608,655 56,458,533 214,051,068 128,767,870 Charge-offs (86,382,882) (42,359,511) (228,732,404) (102,226,061) Recoveries 1 15,421,670 4,521,934 24,978,017 15,017,099 Net charge-offs (70,961,212) (37,837,577) (203,754,387) (87,208,962) Ending Balance $ 144,539,543 $ 133,281,196 $ 144,539,543 $ 133,281,196
Summary of the Past Due Receivables	The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2022: Days Past Due - Recency Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 82,998,807 $ 7,076,046 $ 5,952,005 $ 14,630,210 $ 27,658,261 $ 110,657,068 6 to 17 months 134,510,770 8,584,660 6,300,110 12,850,778 27,735,548 162,246,318 18 to 35 months 131,660,006 7,375,720 5,497,643 10,749,967 23,623,330 155,283,336 36 to 59 months 233,507,760 9,554,628 6,062,913 10,460,529 26,078,070 259,585,830 60+ months 798,337,974 25,843,806 15,352,549 26,657,441 67,853,796 866,191,770 Tax advance loans — — — 20,405 20,405 20,405 Total gross loans 1,381,015,317 58,434,860 39,165,220 75,369,330 172,969,410 1,553,984,727 Unearned interest, insurance and fees (383,291,034) (16,218,182) (10,870,030) (20,918,224) (48,006,436) (431,297,470) Total net loans $ 997,724,283 $ 42,216,678 $ 28,295,190 $ 54,451,106 $ 124,962,974 $ 1,122,687,257 Percentage of period-end gross loans receivable 3.8% 2.5% 4.9% 11.1% The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2022: Days Past Due - Recency Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 145,168,588 $ 13,450,365 $ 14,196,717 $ 25,924,805 $ 53,571,887 $ 198,740,475 6 to 17 months 116,065,794 5,548,699 4,148,743 7,902,330 17,599,772 133,665,566 18 to 35 months 183,697,553 7,220,814 4,903,686 9,118,270 21,242,770 204,940,323 36 to 59 months 193,820,229 5,951,049 3,452,087 5,712,662 15,115,798 208,936,027 60+ months 720,695,865 19,739,361 11,145,251 19,102,672 49,987,284 770,683,149 Tax advance loans 4,744,774 1,062,145 432 15,969 1,078,546 5,823,320 Total gross loans 1,364,192,803 52,972,433 37,846,916 67,776,708 158,596,057 1,522,788,860 Unearned interest, insurance and fees (361,055,818) (14,020,016) (10,016,802) (17,938,208) (41,975,027) (403,030,844) Total net loans $ 1,003,136,985 $ 38,952,417 $ 27,830,114 $ 49,838,500 $ 116,621,030 $ 1,119,758,016 Percentage of period-end gross loans receivable 3.5 % 2.5 % 4.5 % 10.4 % The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2022: Days Past Due - Contractual Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 80,387,487 $ 6,499,221 $ 6,107,020 $ 17,663,341 $ 30,269,582 $ 110,657,069 6 to 17 months 131,366,771 8,013,659 6,864,901 16,000,987 30,879,547 162,246,318 18 to 35 months 128,007,181 6,759,902 5,969,417 14,546,835 27,276,154 155,283,335 36 to 59 months 229,416,636 9,123,648 6,838,567 14,206,979 30,169,194 259,585,830 60+ months 785,037,923 25,440,198 17,667,766 38,045,883 81,153,847 866,191,770 Tax advance loans — — — 20,405 20,405 20,405 Total gross loans 1,354,215,998 55,836,628 43,447,671 100,484,430 199,768,729 1,553,984,727 Unearned interest, insurance and fees (375,853,072) (15,497,061) (12,058,594) (27,888,743) (55,444,398) (431,297,470) Total net loans $ 978,362,926 $ 40,339,567 $ 31,389,077 $ 72,595,687 $ 144,324,331 $ 1,122,687,257 Percentage of period-end gross loans receivable 3.6% 2.8% 6.5% 12.9 % The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2022: Days Past Due - Contractual Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 140,570,461 $ 14,090,712 $ 15,380,836 $ 28,698,466 $ 58,170,014 $ 198,740,475 6 to 17 months 112,465,841 6,032,347 4,922,939 10,244,439 21,199,725 133,665,566 18 to 35 months 177,565,328 8,067,815 6,273,351 13,033,829 27,374,995 204,940,323 36 to 59 months 188,849,569 6,994,891 4,624,136 8,467,431 20,086,458 208,936,027 60+ months 702,984,756 23,645,619 15,443,941 28,608,833 67,698,393 770,683,149 Tax advance loans 4,737,742 1,060,329 — 25,249 1,085,578 5,823,320 Total gross loans 1,327,173,697 59,891,713 46,645,203 89,078,247 195,615,163 1,522,788,860 Unearned interest, insurance and fees (351,258,109) (15,851,316) (12,345,412) (23,576,007) (51,772,735) (403,030,844) Total net loans $ 975,915,588 $ 44,040,397 $ 34,299,791 $ 65,502,240 $ 143,842,428 $ 1,119,758,016 Percentage of period-end gross loans receivable 3.9 % 3.1 % 5.8 % 12.8 %
Financing Receivable, Nonaccrual	The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as year-to-date interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2022 and 2021: Nonaccrual Loans Receivable Customer Tenure As of December 31, 2022 As of March 31, 2022 Interest Income Recognized for the three months ended December 31, 2022 Interest Income Recognized for the three months ended December 31, 2021 Interest Income Recognized for the nine months ended December 31, 2022 Interest Income Recognized for the nine months ended December 31, 2021 0 to 5 months $ 24,968,705 $ 45,227,510 $ 480,947 $ 293,649 $ 1,522,535 $ 858,871 6 to 17 months 23,995,420 15,879,250 450,877 325,759 1,216,091 1,151,316 18 to 35 months 21,946,855 20,745,106 544,689 504,974 1,741,780 1,414,201 36 to 59 months 22,662,926 14,232,388 555,085 325,291 1,575,766 978,378 60+ months 60,891,846 47,565,819 1,711,201 1,193,860 5,006,238 3,782,122 Tax advance loans 144,466 25,249 — — — — Unearned interest, insurance and fees (42,910,972) (38,026,011) — — — — Total $ 111,699,246 $ 105,649,311 $ 3,742,799 $ 2,643,533 $ 11,062,410 $ 8,184,888

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Lease, Cost	The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2022 and 2021: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Lease Cost Finance lease cost $ — $ 105,639 $ 205,975 $ 323,880 Amortization of right-of-use assets — 101,906 204,552 305,718 Interest on lease liabilities — 3,733 1,423 18,162 Operating lease cost $ 6,746,965 $ 6,723,789 $ 21,013,997 $ 20,421,780 Variable lease cost $ 920,991 $ 904,015 $ 2,772,620 $ 2,690,848 Total lease cost $ 7,667,956 $ 7,733,443 $ 23,992,592 $ 23,436,508 The following table reports other information about the Company's leases for the three and nine months ended December 31, 2022 and 2021: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Other Lease Information Cash paid for amounts included in the measurement of lease liabilities $ 6,550,184 $ 6,825,474 $ 19,998,398 $ 20,796,373 Operating cash flows from finance leases — 3,733 1,423 18,162 Operating cash flows from operating leases 6,550,184 6,684,414 19,916,908 20,339,163 Financing cash flows from finance leases — 137,327 80,067 439,048 Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ — $ — $ — Right-of-use assets obtained in exchange for new operating lease liabilities $ 3,447,091 $ 2,763,875 $ 13,912,470 $ 11,840,569 Weighted-average remaining lease term — finance leases — 0.5 years — 0.5 years Weighted average remaining lease term — operating leases 7.1 years 7.1 years 7.1 years 7.1 years Weighted-average discount rate — finance leases — % 6.1 % — % 6.1 % Weighted-average discount rate — operating leases 6.1 % 6.1 % 6.1 % 6.1 %
Operating Lease Maturity	The aggregate annual lease obligations as of December 31, 2022, are as follows: Operating Remainder of 2023 $ 6,357,453 2024 22,784,456 2025 18,108,324 2026 14,629,113 2027 10,545,420 Thereafter 35,219,893 Total undiscounted lease liability $ 107,644,659 Imputed interest 21,634,465 Total discounted lease liability $ 86,010,194
Finance Lease Maturity	The aggregate annual lease obligations as of December 31, 2022, are as follows: Operating Remainder of 2023 $ 6,357,453 2024 22,784,456 2025 18,108,324 2026 14,629,113 2027 10,545,420 Thereafter 35,219,893 Total undiscounted lease liability $ 107,644,659 Imputed interest 21,634,465 Total discounted lease liability $ 86,010,194

AVERAGE SHARE INFORMATION (Tabl

AVERAGE SHARE INFORMATION (Tables)	9 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Summary of Basic and Diluted Average Common Shares Outstanding	The following is a summary of the basic and diluted average common shares outstanding: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Basic: Weighted average common shares outstanding (denominator) 5,761,954 6,118,591 5,743,094 6,119,971 Diluted: Weighted average common shares outstanding 5,761,954 6,118,591 5,743,094 6,119,971 Dilutive potential common shares 2 95,536 285,197 — 304,096 Weighted average diluted shares outstanding (denominator) 5,857,490 6,403,788 5,743,094 6,424,067

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Performance Shares Vesting Based on EPS Targets	The Performance Share performance targets are set forth below. Trailing 4-Quarter EPS Targets for Restricted Stock Eligible for Vesting $16.35 40% $20.45 60% Trailing 4-Quarter EPS Targets for Options Eligible for Vesting $25.30 100%
Fair Value was Estimated at Grant Date Using the Weighted-Average	Fair value was estimated at grant date using the weighted-average assumptions listed below: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Dividend Yield —% —% —% —% Expected Volatility 57.46% 55.71% 57.09% 58.11% Average risk-free rate 3.91% 1.22% 3.59% 0.92% Expected Life 5.8 years 6.0 years 5.8 years 6.1 years
Summary Schedule of Stock Option Activity	Option activity for the nine months ended December 31, 2022 was as follows: Shares Weighted Average Exercise Weighted Average Aggregate Intrinsic Value Options outstanding, beginning of period 348,743 $ 104.38 Granted during period 15,090 96.15 Exercised during period (6,550) 84.67 Forfeited during period (20,636) 119.94 Expired during period (12,372) 77.78 Options outstanding, end of period 324,275 3 $ 104.42 5.9 years $ 262,799 Options exercisable, end of period 122,853 $ 100.21 5.0 years $ 233,927
Intrinsic Value of Options Exercised	The total intrinsic value of options exercised during the periods ended December 31, 2022 and 2021 was as follows: December 31, December 31, Three months ended $ 51,106 $ 4,529,120 Nine months ended $ 481,572 $ 16,070,389
Summary of the Status and Changes Restricted Stock	A summary of the status of the Company’s restricted stock as of December 31, 2022, and changes during the nine months ended December 31, 2022, are presented below: Shares Weighted Average Fair Value at Grant Date Outstanding at March 31, 2022 552,502 $ 102.51 Granted during the period 2,750 138.76 Vested during the period (65,518) 104.13 Forfeited during the period (29,620) 112.70 Outstanding at December 31, 2022 460,114 $ 101.84
Share-Based Compensation Included as a Component of Net Income (Loss)	Total stock-based compensation included as a component of net income (loss) during the three and nine month periods ended December 31, 2022 and 2021 was as follows: Three months ended December 31, Nine months ended December 31, 2022 2021 2022 2021 Stock-based compensation related to equity classified awards: Stock-based compensation related to stock options $ 425,120 $ 664,094 $ 1,869,879 $ 2,517,071 Stock-based compensation related to restricted stock, net of adjustments and exclusive of cancellations 4 (679,443) 3,644,579 5,512,434 10,240,740 Total stock-based compensation related to equity classified awards $ (254,323) $ 4,308,673 $ 7,382,313 $ 12,757,811

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	9 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2022 and 2021. Nine months ended December 31, 2022 2021 Acquisitions: Number of loan portfolios acquired through asset purchases 43 50 Total acquisitions 43 50 Purchase price $ 22,314,902 $ 10,859,984 Tangible assets: Loans receivable, net 27,105,078 9,631,112 Purchase price amount over (below) carrying value of net tangible assets 5 $ (4,790,176) $ 1,228,872 Customer lists $ — $ 952,872 Non-compete agreements $ — $ 276,000

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Aggregate Annual Maturities Of the Notes Payable	The aggregate annual maturities of the Company's debt arrangements as of December 31, 2022 are as follows: Remainder of 2023 $ — 2024 — 2025 426,490,205 2026 — 2027 300,000,000 Total future debt payments $ 726,490,205

ASSETS HELD FOR SALE (Details)

ASSETS HELD FOR SALE (Details)	3 Months Ended
	Sep. 30, 2021 USD ($) building
Discontinued Operations and Disposal Groups [Abstract]
Number of buildings sold	2
Number of buildings	3
Loss on assets held for sale | $	$ 39,000

SUMMARY OF SIGNIFICANT POLICI_3

SUMMARY OF SIGNIFICANT POLICIES (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Accounting Policies [Abstract]
Unamortized deferred origination fees and costs	$ 5,600	$ 6,900

FAIR VALUE (Details)

FAIR VALUE (Details) - USD ($)	9 Months Ended
	Dec. 31, 2022	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Average loan period	8 months
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior unsecured notes payable, net	$ 296,050,414	$ 295,393,991
Senior notes payable	426,490,205	396,972,746
Fair Value, Inputs, Level 1 | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	20,961,825	19,236,322
Fair Value, Inputs, Level 1 | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	20,961,825	19,236,322
Fair Value, Inputs, Level 2 | Carrying Value | Senior notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior unsecured notes payable, net	300,000,000	300,000,000
Fair Value, Inputs, Level 2 | Estimated Fair Value | Senior notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior unsecured notes payable, net	169,959,000	264,639,000
Fair Value, Inputs, Level 3 | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans receivable, net	978,147,714	985,515,154
Fair Value, Inputs, Level 3 | Carrying Value | Senior notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes payable	426,490,205	396,972,746
Fair Value, Inputs, Level 3 | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans receivable, net	978,147,714	985,515,154
Fair Value, Inputs, Level 3 | Estimated Fair Value | Senior notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes payable	$ 426,490,205	$ 396,972,746

LOANS RECEIVABLE AND ALLOWANC_3

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Gross Loans Receivable By Customer Tenure) (Details) - USD ($)	Dec. 31, 2022	Mar. 31, 2022
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	$ 1,553,984,727	$ 1,522,788,860
Tax advance loans
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	20,405	5,823,320
0 to 5 months | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	110,657,069	198,740,475
6 to 17 months | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	162,246,317	133,665,566
18 to 35 months | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	155,283,336	204,940,323
36 to 59 months | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	259,585,830	208,936,027
60+ months | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	$ 866,191,770	$ 770,683,149

LOANS RECEIVABLE AND ALLOWANC_4

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Payment Performance On A Recency Basis) (Details) - USD ($)	Dec. 31, 2022	Mar. 31, 2022
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	$ 1,553,984,727	$ 1,522,788,860
Loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	1,469,474,665	1,472,796,581
Financing receivable, between 1 and 2 years ago	81,075,394	40,616,551
Financing receivable, between 2 and 3 years ago	3,073,266	3,291,728
Financing receivable, between 3 and 4 years ago	287,320	217,524
Financing receivable, between 4 and 5 years ago	40,720	35,183
Financing receivable, more than 5 years ago	12,957	7,973
Loans | Consumer Loan
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	1,553,964,322	1,516,965,540
Loans | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	51,922,222	49,517,859
Financing receivable, between 1 and 2 years ago	6,178,714	2,114,463
Financing receivable, between 2 and 3 years ago	256,692	247,291
Financing receivable, between 3 and 4 years ago	56,562	28,011
Financing receivable, between 4 and 5 years ago	19,357	2,664
Financing receivable, more than 5 years ago	1,314	0
Gross loans receivable	58,434,861	51,910,288
Loans | 61 - 90 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	35,259,645	36,707,960
Financing receivable, between 1 and 2 years ago	3,682,972	989,136
Financing receivable, between 2 and 3 years ago	175,892	130,763
Financing receivable, between 3 and 4 years ago	45,534	13,031
Financing receivable, between 4 and 5 years ago	1,175	5,594
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	39,165,218	37,846,484
Loans | 91 or more days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	66,796,641	64,238,626
Financing receivable, between 1 and 2 years ago	8,345,331	3,239,753
Financing receivable, between 2 and 3 years ago	182,449	248,596
Financing receivable, between 3 and 4 years ago	17,029	24,377
Financing receivable, between 4 and 5 years ago	5,211	5,386
Financing receivable, more than 5 years ago	2,266	4,001
Gross loans receivable	75,348,927	67,760,739
Tax advance loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	20,280	5,801,474
Financing receivable, between 1 and 2 years ago	125	21,846
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	20,405	5,823,320
Tax advance loans | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	1,060,811
Financing receivable, between 1 and 2 years ago	0	1,334
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	0	1,062,145
Tax advance loans | 61 - 90 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	0
Financing receivable, between 1 and 2 years ago	0	432
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	0	432
Tax advance loans | 91 or more days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	20,280	2,922
Financing receivable, between 1 and 2 years ago	125	13,047
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	20,405	15,969
Performing Financing Receivable | Loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	1,315,496,157	1,322,332,136
Financing receivable, between 1 and 2 years ago	62,868,377	34,273,199
Financing receivable, between 2 and 3 years ago	2,458,233	2,665,078
Financing receivable, between 3 and 4 years ago	168,195	152,105
Financing receivable, between 4 and 5 years ago	14,977	21,539
Financing receivable, more than 5 years ago	9,377	3,972
Performing Financing Receivable | Loans | Consumer Loan
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	1,381,015,316	1,359,448,029
Performing Financing Receivable | Tax advance loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	4,737,741
Financing receivable, between 1 and 2 years ago	0	7,033
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	$ 0	$ 4,744,774

LOANS RECEIVABLE AND ALLOWANC_5

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Payment Performance On A Contractual Basis) (Details) - USD ($)	Dec. 31, 2022	Mar. 31, 2022
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	$ 1,553,984,727	$ 1,522,788,860
Loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	1,469,474,665	1,472,796,581
Financing receivable, between 1 and 2 years ago	81,075,394	40,616,551
Financing receivable, between 2 and 3 years ago	3,073,266	3,291,728
Financing receivable, between 3 and 4 years ago	287,320	217,524
Financing receivable, between 4 and 5 years ago	40,720	35,183
Financing receivable, more than 5 years ago	12,957	7,973
Loans | Consumer Loan
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	1,553,964,322	1,516,965,540
Loans | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	51,922,222	49,517,859
Financing receivable, between 1 and 2 years ago	6,178,714	2,114,463
Financing receivable, between 2 and 3 years ago	256,692	247,291
Financing receivable, between 3 and 4 years ago	56,562	28,011
Financing receivable, between 4 and 5 years ago	19,357	2,664
Financing receivable, more than 5 years ago	1,314	0
Gross loans receivable	58,434,861	51,910,288
Loans | 61 - 90 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	35,259,645	36,707,960
Financing receivable, between 1 and 2 years ago	3,682,972	989,136
Financing receivable, between 2 and 3 years ago	175,892	130,763
Financing receivable, between 3 and 4 years ago	45,534	13,031
Financing receivable, between 4 and 5 years ago	1,175	5,594
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	39,165,218	37,846,484
Loans | 91 or more days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	66,796,641	64,238,626
Financing receivable, between 1 and 2 years ago	8,345,331	3,239,753
Financing receivable, between 2 and 3 years ago	182,449	248,596
Financing receivable, between 3 and 4 years ago	17,029	24,377
Financing receivable, between 4 and 5 years ago	5,211	5,386
Financing receivable, more than 5 years ago	2,266	4,001
Gross loans receivable	75,348,927	67,760,739
Tax advance loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	20,280	5,801,474
Financing receivable, between 1 and 2 years ago	125	21,846
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	20,405	5,823,320
Tax advance loans | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	1,060,811
Financing receivable, between 1 and 2 years ago	0	1,334
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	0	1,062,145
Tax advance loans | 61 - 90 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	0
Financing receivable, between 1 and 2 years ago	0	432
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	0	432
Tax advance loans | 91 or more days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	20,280	2,922
Financing receivable, between 1 and 2 years ago	125	13,047
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	20,405	15,969
Performing Financing Receivable | Loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	1,315,496,157	1,322,332,136
Financing receivable, between 1 and 2 years ago	62,868,377	34,273,199
Financing receivable, between 2 and 3 years ago	2,458,233	2,665,078
Financing receivable, between 3 and 4 years ago	168,195	152,105
Financing receivable, between 4 and 5 years ago	14,977	21,539
Financing receivable, more than 5 years ago	9,377	3,972
Performing Financing Receivable | Loans | Consumer Loan
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	1,381,015,316	1,359,448,029
Performing Financing Receivable | Tax advance loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	4,737,741
Financing receivable, between 1 and 2 years ago	0	7,033
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	0	4,744,774
Contractual basis
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	1,553,984,727	1,522,788,860
Contractual basis | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	55,836,628	59,891,713
Contractual basis | 61 - 90 days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	43,447,671	46,645,203
Contractual basis | 91 or more days past due
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	100,484,430	89,078,247
Contractual basis | Loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	1,469,474,665	1,472,796,581
Financing receivable, between 1 and 2 years ago	81,075,393	40,616,550
Financing receivable, between 2 and 3 years ago	3,073,266	3,291,728
Financing receivable, between 3 and 4 years ago	287,320	217,524
Financing receivable, between 4 and 5 years ago	40,721	35,184
Financing receivable, more than 5 years ago	12,957	7,973
Contractual basis | Loans | Consumer Loan
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	1,553,964,322	1,516,965,540
Contractual basis | Loans | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	52,162,519	57,225,953
Financing receivable, between 1 and 2 years ago	3,578,939	1,508,794
Financing receivable, between 2 and 3 years ago	86,368	91,118
Financing receivable, between 3 and 4 years ago	8,801	5,519
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	55,836,627	58,831,384
Contractual basis | Loans | 61 - 90 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	39,792,091	45,276,797
Financing receivable, between 1 and 2 years ago	3,560,584	1,271,187
Financing receivable, between 2 and 3 years ago	91,067	96,233
Financing receivable, between 3 and 4 years ago	3,929	986
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	43,447,671	46,645,203
Contractual basis | Loans | 91 or more days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	81,321,318	79,845,465
Financing receivable, between 1 and 2 years ago	18,003,948	7,922,574
Financing receivable, between 2 and 3 years ago	885,526	1,109,903
Financing receivable, between 3 and 4 years ago	205,410	142,183
Financing receivable, between 4 and 5 years ago	36,378	25,598
Financing receivable, more than 5 years ago	11,446	7,274
Gross loans receivable	100,464,026	89,052,997
Contractual basis | Tax advance loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	20,280	5,801,474
Financing receivable, between 1 and 2 years ago	125	21,846
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	20,405	5,823,320
Contractual basis | Tax advance loans | 30 - 60 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	1,060,329
Financing receivable, between 1 and 2 years ago	0	0
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	0	1,060,329
Contractual basis | Tax advance loans | 61 - 90 days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	0
Financing receivable, between 1 and 2 years ago	0	0
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	0	0
Contractual basis | Tax advance loans | 91 or more days past due
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	20,280	3,404
Financing receivable, between 1 and 2 years ago	125	21,846
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	20,405	25,250
Contractual basis | Performing Financing Receivable | Loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	1,296,198,737	1,290,448,366
Financing receivable, between 1 and 2 years ago	55,931,922	29,913,995
Financing receivable, between 2 and 3 years ago	2,010,305	1,994,474
Financing receivable, between 3 and 4 years ago	69,180	68,836
Financing receivable, between 4 and 5 years ago	4,343	9,586
Financing receivable, more than 5 years ago	1,511	699
Contractual basis | Performing Financing Receivable | Loans | Consumer Loan
Financing Receivable, Recorded Investment [Line Items]
Gross loans receivable	1,354,215,998	1,322,435,956
Contractual basis | Performing Financing Receivable | Tax advance loans
Financing Receivable, Recorded Investment [Line Items]
Financing receivable, up to 1 year ago	0	4,737,741
Financing receivable, between 1 and 2 years ago	0	0
Financing receivable, between 2 and 3 years ago	0	0
Financing receivable, between 3 and 4 years ago	0	0
Financing receivable, between 4 and 5 years ago	0	0
Financing receivable, more than 5 years ago	0	0
Gross loans receivable	$ 0	$ 4,737,741

LOANS RECEIVABLE AND ALLOWANC_6

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Roll Forward of the Allowance for Credit Losses on Our Gross Loans Receivable) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 155,892,100	$ 114,660,240	$ 134,242,862	$ 91,722,288
Provision for credit losses	59,608,655	56,458,533	214,051,068	128,767,870
Charge-offs	(86,382,882)	(42,359,511)	(228,732,404)	(102,226,061)
Recoveries	15,421,670	4,521,934	24,978,017	15,017,099
Net charge-offs	(70,961,212)	(37,837,577)	(203,754,387)	(87,208,962)
Ending Balance	$ 144,539,543	$ 133,281,196	$ 144,539,543	$ 133,281,196

LOANS RECEIVABLE AND ALLOWANC_7

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Summary of Past Due Receivables) (Details) - USD ($)	3 Months Ended	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Mar. 31, 2022
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 1,553,984,727	$ 1,553,984,727	$ 1,522,788,860
Unearned interest, insurance and fees	(5,600,000)	(5,600,000)	(6,900,000)
Charge offs	11,400,000	11,400,000
Proceeds from prior write offs, prior periods		8,400,000
Proceeds from prior write offs, current period	3,000,000
Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	20,405	20,405	5,823,320
30 - 60 days past due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	110,657,069	110,657,069	198,740,475
30 - 60 days past due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	162,246,317	162,246,317	133,665,566
30 - 60 days past due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	155,283,336	155,283,336	204,940,323
30 - 60 days past due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	259,585,830	259,585,830	208,936,027
30 - 60 days past due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	866,191,770	866,191,770	770,683,149
Recency Basis
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	1,553,984,727	1,553,984,727	1,522,788,860
Unearned interest, insurance and fees	(431,297,470)	(431,297,470)	(403,030,844)
Total net loans	$ 1,122,687,257	$ 1,122,687,257	$ 1,119,758,016
Financing receivable, percent past due	11.10%	11.10%	10.40%
Recency Basis | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 20,405	$ 20,405	$ 5,823,320
Recency Basis | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	110,657,068	110,657,068	198,740,475
Recency Basis | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	162,246,318	162,246,318	133,665,566
Recency Basis | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	155,283,336	155,283,336	204,940,323
Recency Basis | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	259,585,830	259,585,830	208,936,027
Recency Basis | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	866,191,770	866,191,770	770,683,149
Recency Basis | Current
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	1,381,015,317	1,381,015,317	1,364,192,803
Unearned interest, insurance and fees	(383,291,034)	(383,291,034)	(361,055,818)
Total net loans	997,724,283	997,724,283	1,003,136,985
Recency Basis | Current | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	0	0	4,744,774
Recency Basis | Current | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	82,998,807	82,998,807	145,168,588
Recency Basis | Current | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	134,510,770	134,510,770	116,065,794
Recency Basis | Current | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	131,660,006	131,660,006	183,697,553
Recency Basis | Current | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	233,507,760	233,507,760	193,820,229
Recency Basis | Current | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	798,337,974	798,337,974	720,695,865
Recency Basis | 30 - 60 days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	58,434,860	58,434,860	52,972,433
Unearned interest, insurance and fees	(16,218,182)	(16,218,182)	(14,020,016)
Total net loans	$ 42,216,678	$ 42,216,678	$ 38,952,417
Financing receivable, percent past due	3.80%	3.80%	3.50%
Recency Basis | 30 - 60 days past due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 0	$ 0	$ 1,062,145
Recency Basis | 30 - 60 days past due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	7,076,046	7,076,046	13,450,365
Recency Basis | 30 - 60 days past due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	8,584,660	8,584,660	5,548,699
Recency Basis | 30 - 60 days past due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	7,375,720	7,375,720	7,220,814
Recency Basis | 30 - 60 days past due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	9,554,628	9,554,628	5,951,049
Recency Basis | 30 - 60 days past due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	25,843,806	25,843,806	19,739,361
Recency Basis | 61 - 90 days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	39,165,220	39,165,220	37,846,916
Unearned interest, insurance and fees	(10,870,030)	(10,870,030)	(10,016,802)
Total net loans	$ 28,295,190	$ 28,295,190	$ 27,830,114
Financing receivable, percent past due	2.50%	2.50%	2.50%
Recency Basis | 61 - 90 days past due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 0	$ 0	$ 432
Recency Basis | 61 - 90 days past due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	5,952,005	5,952,005	14,196,717
Recency Basis | 61 - 90 days past due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	6,300,110	6,300,110	4,148,743
Recency Basis | 61 - 90 days past due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	5,497,643	5,497,643	4,903,686
Recency Basis | 61 - 90 days past due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	6,062,913	6,062,913	3,452,087
Recency Basis | 61 - 90 days past due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	15,352,549	15,352,549	11,145,251
Recency Basis | 91 or more days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	75,369,330	75,369,330	67,776,708
Unearned interest, insurance and fees	(20,918,224)	(20,918,224)	(17,938,208)
Total net loans	$ 54,451,106	$ 54,451,106	$ 49,838,500
Financing receivable, percent past due	4.90%	4.90%	4.50%
Recency Basis | 91 or more days past due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 20,405	$ 20,405	$ 15,969
Recency Basis | 91 or more days past due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	14,630,210	14,630,210	25,924,805
Recency Basis | 91 or more days past due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	12,850,778	12,850,778	7,902,330
Recency Basis | 91 or more days past due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	10,749,967	10,749,967	9,118,270
Recency Basis | 91 or more days past due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	10,460,529	10,460,529	5,712,662
Recency Basis | 91 or more days past due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	26,657,441	26,657,441	19,102,672
Recency Basis | Total Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	172,969,410	172,969,410	158,596,057
Unearned interest, insurance and fees	(48,006,436)	(48,006,436)	(41,975,027)
Total net loans	124,962,974	124,962,974	116,621,030
Recency Basis | Total Past Due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	20,405	20,405	1,078,546
Recency Basis | Total Past Due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	27,658,261	27,658,261	53,571,887
Recency Basis | Total Past Due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	27,735,548	27,735,548	17,599,772
Recency Basis | Total Past Due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	23,623,330	23,623,330	21,242,770
Recency Basis | Total Past Due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	26,078,070	26,078,070	15,115,798
Recency Basis | Total Past Due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	67,853,796	67,853,796	49,987,284
Contractual basis
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	1,553,984,727	1,553,984,727	1,522,788,860
Unearned interest, insurance and fees	(431,297,470)	(431,297,470)	(403,030,844)
Total net loans	$ 1,122,687,257	$ 1,122,687,257	$ 1,119,758,016
Financing receivable, percent past due	12.90%	12.90%	12.80%
Contractual basis | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 20,405	$ 20,405	$ 5,823,320
Contractual basis | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	110,657,069	110,657,069	198,740,475
Contractual basis | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	162,246,318	162,246,318	133,665,566
Contractual basis | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	155,283,335	155,283,335	204,940,323
Contractual basis | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	259,585,830	259,585,830	208,936,027
Contractual basis | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	866,191,770	866,191,770	770,683,149
Contractual basis | Current
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	1,354,215,998	1,354,215,998	1,327,173,697
Unearned interest, insurance and fees	(375,853,072)	(375,853,072)	(351,258,109)
Total net loans	978,362,926	978,362,926	975,915,588
Contractual basis | Current | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	0	0	4,737,742
Contractual basis | Current | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	80,387,487	80,387,487	140,570,461
Contractual basis | Current | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	131,366,771	131,366,771	112,465,841
Contractual basis | Current | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	128,007,181	128,007,181	177,565,328
Contractual basis | Current | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	229,416,636	229,416,636	188,849,569
Contractual basis | Current | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	785,037,923	785,037,923	702,984,756
Contractual basis | 30 - 60 days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	55,836,628	55,836,628	59,891,713
Unearned interest, insurance and fees	(15,497,061)	(15,497,061)	(15,851,316)
Total net loans	$ 40,339,567	$ 40,339,567	$ 44,040,397
Financing receivable, percent past due	3.60%	3.60%	3.90%
Contractual basis | 30 - 60 days past due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 0	$ 0	$ 1,060,329
Contractual basis | 30 - 60 days past due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	6,499,221	6,499,221	14,090,712
Contractual basis | 30 - 60 days past due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	8,013,659	8,013,659	6,032,347
Contractual basis | 30 - 60 days past due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	6,759,902	6,759,902	8,067,815
Contractual basis | 30 - 60 days past due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	9,123,648	9,123,648	6,994,891
Contractual basis | 30 - 60 days past due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	25,440,198	25,440,198	23,645,619
Contractual basis | 61 - 90 days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	43,447,671	43,447,671	46,645,203
Unearned interest, insurance and fees	(12,058,594)	(12,058,594)	(12,345,412)
Total net loans	$ 31,389,077	$ 31,389,077	$ 34,299,791
Financing receivable, percent past due	2.80%	2.80%	3.10%
Contractual basis | 61 - 90 days past due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 0	$ 0	$ 0
Contractual basis | 61 - 90 days past due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	6,107,020	6,107,020	15,380,836
Contractual basis | 61 - 90 days past due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	6,864,901	6,864,901	4,922,939
Contractual basis | 61 - 90 days past due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	5,969,417	5,969,417	6,273,351
Contractual basis | 61 - 90 days past due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	6,838,567	6,838,567	4,624,136
Contractual basis | 61 - 90 days past due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	17,667,766	17,667,766	15,443,941
Contractual basis | 91 or more days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	100,484,430	100,484,430	89,078,247
Unearned interest, insurance and fees	(27,888,743)	(27,888,743)	(23,576,007)
Total net loans	$ 72,595,687	$ 72,595,687	$ 65,502,240
Financing receivable, percent past due	6.50%	6.50%	5.80%
Contractual basis | 91 or more days past due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 20,405	$ 20,405	$ 25,249
Contractual basis | 91 or more days past due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	17,663,341	17,663,341	28,698,466
Contractual basis | 91 or more days past due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	16,000,987	16,000,987	10,244,439
Contractual basis | 91 or more days past due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	14,546,835	14,546,835	13,033,829
Contractual basis | 91 or more days past due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	14,206,979	14,206,979	8,467,431
Contractual basis | 91 or more days past due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	38,045,883	38,045,883	28,608,833
Contractual basis | Total Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	199,768,729	199,768,729	195,615,163
Unearned interest, insurance and fees	(55,444,398)	(55,444,398)	(51,772,735)
Total net loans	144,324,331	144,324,331	143,842,428
Contractual basis | Total Past Due | Tax advance loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	20,405	20,405	1,085,578
Contractual basis | Total Past Due | 0 to 5 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	30,269,582	30,269,582	58,170,014
Contractual basis | Total Past Due | 6 to 17 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	30,879,547	30,879,547	21,199,725
Contractual basis | Total Past Due | 18 to 35 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	27,276,154	27,276,154	27,374,995
Contractual basis | Total Past Due | 36 to 59 months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	30,169,194	30,169,194	20,086,458
Contractual basis | Total Past Due | 60+ months
Financing Receivable, Recorded Investment, Past Due [Line Items]
Gross loans receivable	$ 81,153,847	$ 81,153,847	$ 67,698,393

LOANS RECEIVABLE AND ALLOWANC_8

LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Nonaccrual) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Financing Receivable, Nonaccrual [Line Items]
Uncollected accrued interest reversed	$ 9,400,000	$ 9,700,000	$ 29,900,000	$ 20,300,000
Financing receivable, nonaccrual	111,699,246		111,699,246		$ 105,649,311
Interest Income Recognized	3,742,799	2,643,533	11,062,410	8,184,888
Nonaccrual status
Financing Receivable, Nonaccrual [Line Items]
Unearned interest, insurance and fees	(42,910,972)		(42,910,972)		(38,026,011)
Tax advance loans
Financing Receivable, Nonaccrual [Line Items]
Financing receivable, nonaccrual	144,466		144,466		25,249
Interest Income Recognized	0	0	0	0
0 to 5 months
Financing Receivable, Nonaccrual [Line Items]
Financing receivable, nonaccrual	24,968,705		24,968,705		45,227,510
Interest Income Recognized	480,947	293,649	1,522,535	858,871
6 to 17 months
Financing Receivable, Nonaccrual [Line Items]
Financing receivable, nonaccrual	23,995,420		23,995,420		15,879,250
Interest Income Recognized	450,877	325,759	1,216,091	1,151,316
18 to 35 months
Financing Receivable, Nonaccrual [Line Items]
Financing receivable, nonaccrual	21,946,855		21,946,855		20,745,106
Interest Income Recognized	544,689	504,974	1,741,780	1,414,201
36 to 59 months
Financing Receivable, Nonaccrual [Line Items]
Financing receivable, nonaccrual	22,662,926		22,662,926		14,232,388
Interest Income Recognized	555,085	325,291	1,575,766	978,378
60+ months
Financing Receivable, Nonaccrual [Line Items]
Financing receivable, nonaccrual	60,891,846		60,891,846		$ 47,565,819
Interest Income Recognized	$ 1,711,201	$ 1,193,860	$ 5,006,238	$ 3,782,122

LEASES (Additional Information)

LEASES (Additional Information) (Details)	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Finance lease, term of contract	3 years
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	3 years
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	5 years

LEASES (Lease Cost) (Details)

LEASES (Lease Cost) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Finance lease cost	$ 0	$ 105,639	$ 205,975	$ 323,880
Amortization of right-of-use assets	0	101,906	204,552	305,718
Interest on lease liabilities	0	3,733	1,423	18,162
Operating lease cost	6,746,965	6,723,789	21,013,997	20,421,780
Variable lease cost	920,991	904,015	2,772,620	2,690,848
Total lease cost	7,667,956	7,733,443	23,992,592	23,436,508
Cash paid for amounts included in the measurement of lease liabilities	6,550,184	6,825,474	19,998,398	20,796,373
Operating cash flows from finance leases	0	3,733	1,423	18,162
Operating cash flows from operating leases	6,550,184	6,684,414	19,916,908	20,339,163
Financing cash flows from finance leases	0	137,327	80,067	439,048
Right-of-use assets obtained in exchange for new finance lease liabilities	0	0	0	0
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 3,447,091	$ 2,763,875	$ 13,912,470	$ 11,840,569
Weighted-average remaining lease term — finance leases		6 months		6 months
Weighted average remaining lease term — operating leases	7 years 1 month 6 days	7 years 1 month 6 days	7 years 1 month 6 days	7 years 1 month 6 days
Weighted-average discount rate — finance leases	0%	6.10%	0%	6.10%
Weighted-average discount rate — operating leases	6.10%	6.10%	6.10%	6.10%

LEASES (Aggregate Annual Lease

LEASES (Aggregate Annual Lease Obligations) (Details) - USD ($)	Dec. 31, 2022	Mar. 31, 2022
Operating
Remainder of 2023	$ 6,357,453
2024	22,784,456
2025	18,108,324
2026	14,629,113
2027	10,545,420
Thereafter	35,219,893
Total undiscounted lease liability	107,644,659
Imputed interest	21,634,465
Total discounted lease liability	$ 86,010,194	$ 87,399,049

AVERAGE SHARE INFORMATION (Deta

AVERAGE SHARE INFORMATION (Details) - shares	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Basic:
Weighted average common shares outstanding (in shares)	5,761,954	6,118,591	5,743,094	6,119,971
Diluted:
Weighted average common shares outstanding (in shares)	5,761,954	6,118,591	5,743,094	6,119,971
Dilutive potential common shares (in shares)	95,536	285,197	0	304,096
Weighted average diluted shares outstanding (in shares)	5,857,490	6,403,788	5,743,094	6,424,067
Anti-dilutive shares (in shares)	332,275	376,307	338,154	431,858

STOCK-BASED COMPENSATION (Narra

STOCK-BASED COMPENSATION (Narrative) (Details)	3 Months Ended			9 Months Ended
	Dec. 31, 2022 USD ($) installment $ / shares shares	Jun. 30, 2022 $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2022 USD ($) installment $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Mar. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	144,629			144,629
Vesting percentage				100%
Weighted-average fair value at the grant date (in dollars per share) | $ / shares	$ 44.23		$ 101.73	$ 53.51	$ 97.65
Compensation related to stock option and restricted stock plans, net of taxes and adjustments | $				$ 7,382,313	$ 12,757,811
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of authorized common stock reserved for issuance (in shares)	3,350,000			3,350,000
Options outstanding (in shares)	324,275			324,275		348,743
Total unrecognized stock-based compensation expense related to non-vested stock options | $	$ 3,600,000			$ 3,600,000
Weighted average period for recognition				2 years
Compensation related to stock option and restricted stock plans, net of taxes and adjustments | $	$ 425,120		$ 664,094	$ 1,869,879	2,517,071
Employee Stock Option | Scenario 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)	88,248			88,248
Employee Stock Option | Scenario 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)	113,174			113,174
Employee Stock Option | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years
Employee Stock Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option, expiration period				10 years
Vesting period				6 years
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of installments | installment	6			6
Awards granted (in shares)		4,062		2,750
Grant date fair value (in dollars per share) | $ / shares		$ 188.38		$ 138.76
Compensation related to stock option and restricted stock plans, net of taxes and adjustments | $	$ (679,443)		$ 3,644,579	$ 5,512,434	$ 10,240,740
Unvested restricted stock awards | $	$ 5,400,000			$ 5,400,000
Service Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				10 years
Number of installments | installment	6			6
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				10 years
Weighted average period for recognition				1 year 7 months 6 days

STOCK-BASED COMPENSATION (Share

STOCK-BASED COMPENSATION (Share and Options Performance Targets) (Details)	9 Months Ended
	Dec. 31, 2022 $ / shares
Target 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
EPS target (in dollars per share)	$ 16.35
Vesting percentage	40%
Target 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
EPS target (in dollars per share)	$ 20.45
Vesting percentage	60%
Target 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
EPS target (in dollars per share)	$ 25.30
Vesting percentage	100%

STOCK-BASED COMPENSATION (Grant

STOCK-BASED COMPENSATION (Grants Date Using The Weighted-Average Assumptions) (Details)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
Dividend Yield	0%	0%	0%	0%
Expected Volatility	57.46%	55.71%	57.09%	58.11%
Average risk-free rate	3.91%	1.22%	3.59%	0.92%
Expected Life	5 years 9 months 18 days	6 years	5 years 9 months 18 days	6 years 1 month 6 days

STOCK-BASED COMPENSATION (Stock

STOCK-BASED COMPENSATION (Stock Option Activity and Intrinsic Value) (Details) - Stock Options Plans - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Options Activity [Roll Forward]
Options outstanding, beginning of year (in shares)			348,743
Granted (in shares)			15,090
Exercised (in shares)			(6,550)
Forfeited (in shares)			(20,636)
Expired (in shares)			(12,372)
Options outstanding, end of period (in shares)	324,275		324,275
Options exercisable, end of period (in shares)	122,853		122,853
Weighted Average Exercise Price
Options outstanding, beginning of year (in dollars per share)			$ 104.38
Granted (in dollars per share)			96.15
Exercised (in dollars per share)			84.67
Forfeited (in dollars per share)			119.94
Expired (in dollars per share)			77.78
Options outstanding, end of period (in dollars per share)	$ 104.42		104.42
Options exercisable, end of period (in dollars per share)	$ 100.21		$ 100.21
Stock Option Activity Additional Disclosures [Abstract]
Weighted-average remaining contractual term, options outstanding, end of period			5 years 10 months 24 days
Weighted-average remaining contractual terms, options exercisable, end of period			5 years
Aggregate intrinsic value, options outstanding, end of period	$ 262,799		$ 262,799
Aggregate intrinsic value, options exercisable, end of period	233,927		233,927
Intrinsic value of options exercised	$ 51,106	$ 4,529,120	$ 481,572	$ 16,070,389

STOCK-BASED COMPENSATION (Compa

STOCK-BASED COMPENSATION (Company Restricted Stock and Total Stock-Based Compensation) (Details) - USD ($)	3 Months Ended			9 Months Ended
	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Weighted Average Fair Value at Grant Date
Compensation related to stock option and restricted stock plans, net of taxes and adjustments				$ 7,382,313	$ 12,757,811
Restricted stock expense	$ 2,100,000
Stock Options Plans
Weighted Average Fair Value at Grant Date
Compensation related to stock option and restricted stock plans, net of taxes and adjustments	$ 425,120		$ 664,094	$ 1,869,879	2,517,071
Restricted Stock
Shares
Outstanding at beginning of year (in shares)		552,502		552,502
Granted during the period (in shares)		4,062		2,750
Vested during the period (in shares)				(65,518)
Forfeited during the period (in shares)				(29,620)
Outstanding at end of period (in shares)	460,114			460,114
Weighted Average Fair Value at Grant Date
Outstanding at beginning period (in dollars per share)		$ 102.51		$ 102.51
Granted during the period (in shares)		$ 188.38		138.76
Vested during the period (in dollars per share)				104.13
Forfeited during the period (in dollars per share)				112.70
Outstanding at ending period (in dollars per share)	$ 101.84			$ 101.84
Compensation related to stock option and restricted stock plans, net of taxes and adjustments	$ (679,443)		3,644,579	$ 5,512,434	10,240,740
Shares forfeited, expense	2,800,000
Equity Securities
Weighted Average Fair Value at Grant Date
Compensation related to stock option and restricted stock plans, net of taxes and adjustments	$ (254,323)		$ 4,308,673	$ 7,382,313	$ 12,757,811

ACQUISITIONS (Details)

ACQUISITIONS (Details)	9 Months Ended
	Dec. 31, 2022 USD ($) acquisition	Dec. 31, 2021 USD ($) acquisition
Business Acquisition [Line Items]
Number of loan portfolios acquired through asset purchases | acquisition	43	50
Total acquisitions | acquisition	43	50
Loans receivable, net	$ 27,105,078	$ 9,631,112
Purchase price amount over (below) carrying value of net tangible assets	(4,790,176)	1,228,872
Customer lists	0	952,872
Non-compete agreements	0	276,000
Gain on acquisition, net of income tax	$ 3,708,344	0
Average loan period	8 months
Insurance And Other Income, Net
Business Acquisition [Line Items]
Gain on acquisition, net of income tax	$ 4,800,000
Income tax related to asset acquisition	1,100,000
Series of Individually Immaterial Business Acquisitions
Business Acquisition [Line Items]
Purchase price	$ 22,314,902	$ 10,859,984

DEBT (Narrative) (Details)

DEBT (Narrative) (Details)				9 Months Ended
	Nov. 23, 2022	Nov. 22, 2022	Sep. 27, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2022 USD ($)	Sep. 26, 2021 USD ($)
Line of Credit Facility [Line Items]
Letters of credit outstanding, amount				$ 300,000
Senior unsecured notes payable, net				296,050,414		$ 295,393,991
Senior notes | Fair Value, Inputs, Level 2 | Carrying Value
Line of Credit Facility [Line Items]
Senior unsecured notes payable, net				300,000,000		$ 300,000,000
Senior notes | Senior Notes Due 2026
Line of Credit Facility [Line Items]
Interest rate, percentage			7%
Redemption price, percentage of equity offerings			40%
Senior notes | Senior Notes Due 2026 | Period One
Line of Credit Facility [Line Items]
Redemption price percent			100%
Senior notes | Senior Notes Due 2026 | Period Two
Line of Credit Facility [Line Items]
Redemption price percent			107%
Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity				685,000,000
Accordion feature			$ 785,000,000				$ 685,000,000
Advance rate	62%	74%
Amount outstanding				$ 426,500,000
Extension period				1 year
Interest rate, percentage				3.50%
Commitment fee percentage				0.50%
Unused borrowing capacity, fee				$ 900,000	$ 1,000,000
Interest rate, effective percentage				6.80%		5.50%
Unused amount available				$ 258,200,000
Debt covenants minimum net worth				$ 325,000,000
Expiration period				60 days
Revolving Credit Facility | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate (in hundredths)				0.10%
Revolving Credit Facility | Scenario 1
Line of Credit Facility [Line Items]
Fixed conversion ratio	1.25
Debt covenant, maximum ratio of total debt	2.5
Debt covenant, maximum collateral performance indicator percentage	28%
Revolving Credit Facility | Scenario 2
Line of Credit Facility [Line Items]
Fixed conversion ratio	1.15
Debt covenant, maximum ratio of total debt	2.25
Debt covenant, maximum collateral performance indicator percentage	26%
Revolving Credit Facility | Scenario 3
Line of Credit Facility [Line Items]
Fixed conversion ratio	1.50
Debt covenant, maximum ratio of total debt	2
Revolving Credit Facility | Scenario4
Line of Credit Facility [Line Items]
Fixed conversion ratio	2
Debt covenant, maximum ratio of total debt	2.25
Revolving Credit Facility | Scenario 5
Line of Credit Facility [Line Items]
Fixed conversion ratio	2.75
Debt covenant, maximum ratio of total debt	2.5
Revolving Credit Facility | Scenario 6
Line of Credit Facility [Line Items]
Fixed conversion ratio	2
Revolving Credit Facility | Sub-Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 1,500,000
Minimum | Revolving Credit Facility
Line of Credit Facility [Line Items]
Interest rate, percentage				4.50%

DEBT (Debt Maturities) (Details

DEBT (Debt Maturities) (Details)	Dec. 31, 2022 USD ($)
Debt Disclosure [Abstract]
Remainder of 2023	$ 0
2024	0
2025	426,490,205
2026	0
2027	300,000,000
Total future debt payments	$ 726,490,205

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Total gross unrecognized tax benefits including interest	$ 1,100,000		$ 1,100,000	$ 2,200,000
Unrecognized tax benefits	800,000		800,000	$ 2,000,000
Gross unrecognized tax benefits, limitations and settlement with taxing authorities	500,000		500,000
Accrued gross interest	$ 271,500		271,500
Gross interest expense			$ 284,000
Effective income tax rate reconciliation, percent	9.70%	5.10%